Insulin secretion is controlled by a complex set of factors that include not only glucose but amino acids, catecholamines, and intestinal hormones. We report that a novel glucagon-like peptide, co-encoded with glucagon in the glucagon gene is a potent insulinotropic factor. The glucagon gene encodes a proglucagon that contains in its sequence glucagon and additional glucagon-like peptides (GLPs). These GLPs are liberated from proglucagon in both the pancreas and intestines. GLP-I exists in at least two forms: 37 amino acids GLP-I(1-37), and 31 amino acids, GLP-I(7-37). We studied the effects of synthetic GLP-Is on insulin secretion in the isolated perfused rat pancreas. In the presence of 6.6 mM glucose, GLP-I(7-37) is a potent stimulator of insulin secretion at concentrations as low as 5 X 10(-11) M (3- to 10-fold increases over basal). GLP-I(1-37) had no effect on insulin secretion even at concentrations as high as 5 X 10(-7) M. The earlier demonstration of specific liberation of GLP-I(7-37) in the intestine and pancreas, and the magnitude of the insulinotropic effect at such low concentrations, suggest that GLP-I(7-37) participates in the physiological regulation of insulin secretion. Images
Svetlana Mojsov, Gordon C. Weir, Joel F. Habener
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1985 | 1964 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 2 | 23 | 12 | 13 | 21 | 12 | 24 | 25 | 18 | 31 | 19 | 35 | 24 | 15 | 130 | 39 | 17 | 23 | 16 | 18 | 14 | 13 | 12 | 9 | 11 | 16 | 11 | 13 | 10 | 18 | 17 | 12 | 13 | 18 | 11 | 12 | 11 | 10 | 5 | 1 | 1 | 755 |
Title and authors | Publication | Year |
---|---|---|
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
He X, Zhao W, Li P, Zhang Y, Li G, Su H, Lu B, Pang Z |
Frontiers in Pharmacology | 2025 |
Glucose-dependent insulinotropic polypeptide (GIP)
Müller TD, Adriaenssens A, Ahrén B, Blüher M, Birkenfeld AL, Campbell JE, Coghlan MP, D'Alessio D, Deacon CF, DelPrato S, Douros JD, Drucker DJ, Figueredo Burgos NS, Flatt PR, Finan B, Gimeno RE, Gribble FM, Hayes MR, Hölscher C, Holst JJ, Knerr PJ, Knop FK, Kusminski CM, Liskiewicz A, Mabilleau G, Mowery SA, Nauck MA, Novikoff A, Reimann F, Roberts AG, Rosenkilde MM, Samms RJ, Scherer PE, Seeley RJ, Sloop KW, Wolfrum C, Wootten D, DiMarchi RD, Tschöp MH |
Molecular Metabolism | 2025 |
Targeting the incretin system in obesity and type 2 diabetes mellitus.
Ansari S, Khoo B, Tan T |
Nature reviews. Endocrinology | 2024 |
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets
Reed J, Bain SC, Kanamarlapudi V |
2024 | |
A comprehensive in-vitro/in-vivo screening toolbox for the elucidation of glucose homeostasis modulating properties of plant extracts (from roots) and its bioactives
Bauer I, Rimbach G, Cordeiro S, Bosy-Westphal A, Weghuber J, Ipharraguerre IR, Lüersen K |
Frontiers in pharmacology | 2024 |
Impacts of different pancreatic resection ranges on endocrine function in Suncus murinus
Li RJ, Yang T, Zeng YH, Natsuyama Y, Ren K, Li J, Nagakawa Y, Yi SQ |
World journal of gastrointestinal surgery | 2024 |
Transforming Obesity: The Advancement of Multi-Receptor Drugs
Kusminski CM, Perez-Tilve D, Müller TD, DiMarchi RD, Tschöp MH, Scherer PE |
Cell | 2024 |
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu QK |
Frontiers in Endocrinology | 2024 |
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng JN, Jin T |
2024 | |
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Hoffman S, Adeli K |
2024 | |
A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion
Montaner M, Denom J, Simon V, Jiang W, Holt MK, Brierley DI, Rouch C, Foppen E, Kassis N, Jarriault D, Khan D, Eygret L, Mifsud F, Hodson DJ, Broichhagen J, Van Oudenhove L, Fioramonti X, Gault V, Cota D, Reimann F, Gribble FM, Migrenne-Li S, Trapp S, Gurden H, Magnan C |
Nature Communications | 2024 |
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management.
Holst JJ |
Nature metabolism | 2024 |
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff A, Müller TD |
Physiology | 2024 |
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J |
Signal Transduction and Targeted Therapy | 2024 |
Obesity-drug pioneers win prestigious Lasker Award for medical science.
Lenharo M |
Nature | 2024 |
The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity
Friedman JM |
Proceedings of the National Academy of Sciences of the United States of America | 2024 |
QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award
Nair P |
Proceedings of the National Academy of Sciences of the United States of America | 2024 |
Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of Obesity.
Parums DV |
Medical science monitor : international medical journal of experimental and clinical research | 2024 |
Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1.
Ardehali H |
The Journal of clinical investigation | 2024 |
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
Jin T, Chen YE |
Cardiovascular drugs and therapy | 2024 |
Incretin and glucagon receptor polypharmacology in chronic kidney disease
McFarlin BE, Duffin KL, Konkar A |
American Journal of Physiology - Endocrinology and Metabolism | 2024 |
Annual Prize Lecture 2024: Endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes
Holst JJ |
The Journal of Physiology | 2024 |
Design, Structure–Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor Agonists
Sawyer JR, Audie JA, Swanson J, Diller D, Santiago S, Gribkoff VK, Ackerman A, Hruby VJ, Gobbo G, Bellucci MA, Glauser WA, Pentelute BL, Sawyer TK |
Molecules | 2024 |
The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties
Lu C, Xu C, Yang J |
Medicina | 2024 |
A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure
Gul U, Aung T, Martin M, Farrukh DN, Shah PC, Lovely ZS, Marroquín León E, Alansaari M, Maini S, Fariduddin MM, Ullah A, Nazir Z |
Cureus | 2024 |
Therapeutics in Metabolic Diseases.
Natesan V |
Advances in experimental medicine and biology | 2023 |
GLP-1R Signaling and Functional Molecules in Incretin Therapy
Wan W, Qin Q, Xie L, Zhang H, Wu F, Stevens RC, Liu Y |
Molecules (Basel, Switzerland) | 2023 |
Dual gut hormone receptor agonists for diabetes and obesity.
Bass J, Tschöp MH, Beutler LR |
Journal of Clinical Investigation | 2023 |
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond.
Viljoen A, Bain SC |
2023 | |
The expanding incretin universe: from basic biology to clinical translation.
Drucker DJ, Holst JJ |
Diabetologia | 2023 |
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney AC, Das S, Kumar D, McKinney MP, Cai B, Yurdagul A Jr, Rom O |
Frontiers in Cardiovascular Medicine | 2023 |
Incretin hormones and type 2 diabetes.
Nauck MA, Müller TD |
Diabetologia | 2023 |
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application
Campbell JE, Müller TD, Finan B, DiMarchi RD, Tschöp MH, D\u2019Alessio DA |
Cell Metabolism | 2023 |
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist.
Cho YK, La Lee Y, Jung CH |
Journal of Lipid and Atherosclerosis | 2023 |
The Role of Genistein in Mammalian Reproduction.
Guelfi G, Pasquariello R, Anipchenko P, Capaccia C, Pennarossa G, Brevini TAL, Gandolfi F, Zerani M, Maranesi M |
Molecules (Basel, Switzerland) | 2023 |
Comparison of SGLT1, SGLT2, and Dual Inhibitor biological activity in treating Type 2 Diabetes Mellitus
Azizogli AR, Vitti MR, Mishra R, Osorno L, Heffernan C, Kumar VA |
2023 | |
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
Folli F, Finzi G, Manfrini R, Galli A, Casiraghi F, Centofanti L, Berra C, Fiorina P, Davalli A, La Rosa S, Perego C, Higgins PB |
American journal of physiology. Endocrinology and metabolism | 2023 |
Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β -cell dysfunction
N Esser, S Mongovin, J Parilla, B Barrow, T Mundinger, B Fountaine, M Larmore, J Castillo, R Akter, R Hull, S Zraika |
American journal of physiology. Endocrinology and metabolism | 2022 |
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
Sharma A, Virmani T, Sharma A, Chhabra V, Kumar G, Pathak K, Alhalmi A |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2022 |
State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions
Lavin KM, Coen PM, Baptista LC, Bell MB, Drummer D, Harper SA, Lixandrão ME, McAdam JS, O\u2019Bryan SM, Ramos S, Roberts LM, Vega RB, Goodpaster BH, Bamman MM, Buford TW |
Comprehensive Physiology | 2022 |
14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing
Holter MM, Phuong DJ, Lee I, Saikia M, Weikert L, Fountain S, Anderson ET, Fu Q, Zhang S, Sloop KW, Cummings BP |
Science Advances | 2022 |
Physiological Systems in Promoting Frailty
Perazza LR, Brown-Borg HM, Thompson LV |
Comprehensive Physiology | 2022 |
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology.
Sebastián-Martín A, Sánchez BG, Mora-Rodríguez JM, Bort A, Díaz-Laviada I |
Biomedicines | 2022 |
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion.
Hjørne AP, Modvig IM, Holst JJ |
Metabolites | 2022 |
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
Pang J, Feng JN, Ling W, Jin T |
Acta pharmaceutica Sinica. B | 2022 |
Safety and effectiveness of newer antidiabetic medications during Ramadan fasting and safety of Ramadan fasting after bariatric surgery.
Ahmed M, Badi S, Elidrisi A, Husain NE, Zainudin SB, Mahmood A, Abubaker NE, Alghamdi AS, Ahmed MH |
2022 | |
The Anti-Inflammatory Effect of Novel Antidiabetic Agents.
Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis K, Tousoulis D |
2022 | |
The importance of estradiol for body weight regulation in women.
Vigil P, Meléndez J, Petkovic G, Del Río JP |
Frontiers in Endocrinology | 2022 |
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease.
Du H, Meng X, Yao Y, Xu J |
Frontiers in Endocrinology | 2022 |
Development of sandwich ELISAs for detecting glucagon-like peptide-1 secretion from intestinal L-cells and their application in STC-1 cells and mice.
Odongo K, Hironao KY, Yamashita Y, Ashida H |
Journal of Clinical Biochemistry and Nutrition | 2022 |
The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
MA Nauck, DR Quast, J Wefers, AF Pfeiffer |
Diabetes, obesity & metabolism | 2021 |
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
L D'Marco, V Morillo, JL Gorriz, MK Suarez, M Nava, Á Ortega, H Parra, N Villasmil, J Rojas-Quintero, V Bermúdez, M Wallner |
Journal of Diabetes Research | 2021 |
AMPK in the brain: its roles in glucose and neural metabolism
R Muraleedharan, B Dasgupta |
The FEBS journal | 2021 |
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
J Rosenberg, J Jacob, P Desai, J Park, L Donovan, JY Kim |
Journal of Obesity & Metabolic Syndrome | 2021 |
Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo
Y Dong, J Carty, N Goldstein, Z He, E Hwang, D Chau, B Wallace, A Kabahizi, L Lieu, Y Peng, Y Gao, L Hu, JN Betley, KW Williams |
Molecular Metabolism | 2021 |
The specification and function of enteroendocrine cells in Drosophila and mammals: a comparative review
X Guo, J Lv, |
The FEBS journal | 2021 |
GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
QX Li, H Gao, YX Guo, BY Wang, R Hua, L Gao, HW Shang, X Lu, JD Xu |
Frontiers in Endocrinology | 2021 |
Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
N Tanday, PR Flatt, N Irwin |
British Journal of Pharmacology | 2021 |
Editorial: Proglucagon-Derived Peptides
PR Flatt, FK Knop, AI Tarasov |
Frontiers in Endocrinology | 2021 |
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
J Helmstädter, K Keppeler, L Küster, T Münzel, A Daiber, S Steven |
British Journal of Pharmacology | 2021 |
The incretin/glucagon system as a target for pharmacotherapy of obesity.
Del Prato S, Gallwitz B, Holst JJ, Meier JJ |
Obesity reviews : an official journal of the International Association for the Study of Obesity | 2021 |
Multi-omic Approaches to Identify Genetic Factors in Metabolic Syndrome
Clark KC, Kwitek AE |
Comprehensive Physiology | 2021 |
On premises and principles for measurement of gastrointestinal peptide hormones
NJ Albrechtsen, JF Rehfeld |
Peptides | 2021 |
Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior
S Jones, S Luo, HM Dorton, AG Yunker, B Angelo, A Defendis, JR Monterosso, KA Page |
Frontiers in Endocrinology | 2021 |
Effective and safe delivery of GLP-1AR and FGF-21 plasmids using amino-functionalized dual-mesoporous silica nanoparticles in vitro and in vivo
S Geng, L Qin, Y He, X Li, M Yang, L Li, D Liu, Y Li, D Niu, G Yang |
Biomaterials | 2021 |
The islet’s bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies
S ORahilly |
Cell | 2021 |
Is there a role for glucagon‐like peptide‐1 receptor agonists in the treatment of male infertility?
R Cannarella, AE Calogero, RA Condorelli, EA Greco, A Aversa, SL Vignera |
Andrologia | 2021 |
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
QG Karwi, KL Ho, S Pherwani, EB Ketema, QY Sun, GD Lopaschuk |
Cardiovascular Research | 2021 |
Прямое действие синтетического аналога глюкагон-подобного пептида 1-го типа, лираглутида, на зрелые адипоциты реализуется через аденилатциклаза-зависимое усиление инсулиновой чувствительности
ЕД Мамонтова, СС Мичурина, ЮС Стафеев, ЕЛ Соркина, ИА Скляник, ЕО Кокшарова, МЮ Меньшиков, МВ Шестакова, ЕВ Парфёнова |
2021 | |
Sodium Glucose Transporter, Type 2 (SGLT2) Inhibitors (SGLT2i) and Glucagon-Like Peptide 1-Receptor Agonists: Newer Therapies in Whole-Body Glucose Stabilization
BD Shepard, CM Ecelbarger |
Seminars in Nephrology | 2021 |
The incretin/glucagon system as a target for pharmacotherapy of obesity
SD Prato, B Gallwitz, JJ Holst, JJ Meier |
Obesity reviews : an official journal of the International Association for the Study of Obesity | 2021 |
Development of innovative tools for investigation of nutrient-gut interaction
WK Huang, C Xie, RL Young, JB Zhao, H Ebendorff-Heidepriem, KL Jones, CK Rayner, TZ Wu |
World journal of gastroenterology : WJG | 2020 |
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
K Stemmer, B Finan, RD DiMarchi, MH Tschöp, TD Müller |
Advanced Drug Delivery Reviews | 2020 |
The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
MA Nauck |
Metabolism | 2020 |
AMPK in the Ventromedial Nucleus of the Hypothalamus: A Key Regulator for Thermogenesis
H Liu, Y Xu, F Hu |
Frontiers in Endocrinology | 2020 |
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
MA Nauck, DR Quast, J Wefers, JJ Meier |
Molecular Metabolism | 2020 |
Reframing appetitive reinforcement learning and reward valuation as effects mediated by hippocampal-dependent behavioral inhibition
S Jones, A Hyde, TL Davidson |
Nutrition research (New York, N.Y.) | 2020 |
Glucagon-like Peptide-1: Actions and Influence on Pancreatic Hormone Function
Davis EM, Sandoval DA |
Comprehensive Physiology | 2020 |
GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists
JJ Holst, MM Rosenkilde |
The Journal of clinical endocrinology and metabolism | 2020 |
Engineering Xaa-Pro dipeptidyl aminopeptidase for specific cleavage of glucagon and glucagon-like peptide 1 from fusion proteins
E Vernet, MØ Pedersen, H Thøgersen, AC Shaw |
Protein Expression and Purification | 2020 |
The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone
V Marks |
Peptides | 2020 |
Obesity and Diabetes: Scientific Advances and Best Practice
J Faintuch, S Faintuch |
2020 | |
Aging-related modifications to G protein-coupled receptor signaling diversity
J van Gastel, H Leysen, J Boddaert, L van Genechten, LM Luttrell, B Martin, S Maudsley |
Pharmacology & Therapeutics | 2020 |
CNS-targeting pharmacological interventions for the metabolic syndrome
Kerstin Stemmer, Timo D. Müller, Richard DiMarchi, Paul T. Pfluger, Matthias H. Tschoep |
Journal of Clinical Investigation | 2019 |
Incretins in obesity and diabetes
CW Chia, JM Egan |
Annals of the New York Academy of Sciences | 2019 |
The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism
Y Yu, F Raka, K Adeli |
Journal of Clinical Medicine | 2019 |
Intestinal Fructose and Glucose Metabolism in Health and Disease
B Merino, CM Fernández-Díaz, I Cózar-Castellano, G Perdomo |
Nutrients | 2019 |
The Discovery and Development of Liraglutide and Semaglutide
LB Knudsen, J Lau |
Frontiers in Endocrinology | 2019 |
Glucagon-like peptide 1 (GLP-1)
TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, A Fritsche, F Gribble, HJ Grill, JF Habener, JJ Holst, W Langhans, JJ Meier, MA Nauck, D Perez-Tilve, A Pocai, F Reimann, DA Sandoval, TW Schwartz, RJ Seeley, K Stemmer, M Tang-Christensen, SC Woods, RD DiMarchi, MH Tschöp |
Molecular Metabolism | 2019 |
Intestinal electrical stimulation attenuates hyperglycemia and prevents loss of pancreatic β cells in type 2 diabetic Goto–Kakizaki rats
X Ouyang, S Li, Y Tan, L Lin, J Yin, JD Chen |
Nutrition and Diabetes | 2019 |
Regulation of Memory Function by Feeding-Relevant Biological Systems: Following the Breadcrumbs to the Hippocampus
AN Suarez, EE Noble, SE Kanoski |
Frontiers in molecular neuroscience | 2019 |
Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment
MM Chen, JJ Cai, Y Yu, ZG She, H Li |
Gene expression | 2019 |
Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity
LB Knudsen |
2019 | |
Glucagon, GLP-1 and Thermogenesis
I González-García, E Milbank, C Diéguez, M López, C Contreras |
International journal of molecular sciences | 2019 |
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
JJ Holst |
Frontiers in Endocrinology | 2019 |
Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
L Zhu, J Zhou, Y Pan, J Lv, Y Liu, S Yu, Y Zhang |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2019 |
Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date.
Pearson S, Kietsiriroje N, Ajjan RA |
Diabetes, metabolic syndrome and obesity : targets and therapy | 2019 |
Curcuma supplementation in high-fat-fed C57BL/6 mice: no beneficial effect on lipid and glucose profile or prevention of weight gain
CB Silva, PG Fassini, LN Ramalho, EC da Conceição, AJ Zordan, D Carlos, VM Suen |
European Journal of Nutrition | 2019 |
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
C F. |
Frontiers in Endocrinology | 2019 |
Improving Effects of Peptides on Brain Malfunction and Intranasal Delivery of Those Derivatives to the Brain
JI Oka |
YAKUGAKU ZASSHI | 2019 |
Dietary Flavonoids for Immunoregulation and Cancer: Food Design for Targeting Disease
J Ahn-Jarvis, A Parihar, A Doseff |
Antioxidants | 2019 |
Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency
SE Alavi, PJ Cabot, PM Moyle |
Molecular Pharmaceutics | 2019 |
Enteroendocrine Connections in Congenital Isolated GH Deficiency Due to a GHRH Receptor Gene Mutation
AA Oliveira-Santos, R Salvatori, MC Nogueira, AC Bueno, CS Barros-Oliveira, ÂC Leal, CG Marinho, NP Damascena, DA Oliveira, MA Melo, CR Oliveira, FO da Costa, JS dos Santos, PF Santos, VC Campos, EG Santos, EV Melo, ML Barbosa, IE Rocha, M de Castro, MH Aguiar-Oliveira |
The Journal of clinical endocrinology and metabolism | 2019 |
Molecular evolution of GIP and Exendin and their receptors
DM Irwin |
Peptides | 2019 |
The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone
V Marks |
Peptides | 2019 |
The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective
PB Jeppesen |
Digestive Diseases and Sciences | 2019 |
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome
DJ Drucker |
2019 | |
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
C Clemmensen, B Finan, T Müller, R DiMarchi, M Tschöp, S Hofmann |
Nature Reviews Endocrinology | 2018 |
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
TD Müller, C Clemmensen, B Finan, RD DiMarchi, MH Tschöp, B Holst |
Pharmacological reviews | 2018 |
Liraglutide Enhances the Activity of the ACE-2/Ang(1–7)/Mas Receptor Pathway in Lungs of Male Pups from Food-Restricted Mothers and Prevents the Reduction of SP-A
J Fandiño, AA Vaz, L Toba, M Romaní-Pérez, L González-Matías, F Mallo, Y Diz-Chaves |
International Journal of Endocrinology | 2018 |
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
ME Capozzi, RD DiMarchi, MH Tschöp, B Finan, JE Campbell |
Endocrine reviews | 2018 |
GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice
P Kumari, M Nakata, BY Zhang, Z Otgon-Uul, T Yada |
Biochemical and Biophysical Research Communications | 2018 |
Hypoglycemic Effects of Intestinal Electrical Stimulation by Enhancing Nutrient-Stimulated Secretion of GLP-1 in Rats
F Ye, Y Liu, S Li, JD Chen |
Obesity Surgery | 2018 |
Incretin hormones: Their role in health and disease
MA Nauck, JJ Meier |
Diabetes, obesity & metabolism | 2018 |
Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
HY Cai, JT Yang, ZJ Wang, J Zhang, W Yang, MN Wu, JS Qi |
Biochemical and Biophysical Research Communications | 2018 |
The Origin and Understanding of the Incretin Concept
JF Rehfeld |
Frontiers in Endocrinology | 2018 |
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
C F. |
Peptides | 2018 |
Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control
LL Lehrskov, MP Lyngbaek, L Soederlund, GE Legaard, JA Ehses, SE Heywood, NJ Albrechtsen, JJ Holst, K Karstoft, BK Pedersen, H Ellingsgaard |
Cell Metabolism | 2018 |
Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure
T Kimura, A Obata, M Shimoda, H Hirukawa, Y Kanda-Kimura, Y Nogami, K Kohara, S Nakanishi, T Mune, K Kaku, H Kaneto |
Diabetes & Metabolism | 2018 |
A surface plasmon resonance assay for characterisation and epitope mapping of anti-GLP-1 antibodies
L Thomsen, L Gurevich |
Journal of molecular recognition : JMR | 2018 |
T1R2 receptor-mediated glucose sensing in the upper intestine potentiates glucose absorption through activation of local regulatory pathways
K Smith, E Karimian-Azari, TE LaMoia, T Hussain, V Vargova, K Karolyi, PP Veldhuis, JP Arnoletti, SG de la Fuente, RE Pratley, TF Osborne, GA Kyriazis |
Molecular Metabolism | 2018 |
Exenatide preserves trabecular bone microarchitecture in experimental ovariectomized rat model
E Eminov, I Hortu, L Akman, O Erbas, A Yavasoglu, T Cirpan |
Archives of Gynecology and Obstetrics | 2018 |
Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice
R Hytting-Andreasen, E Balk-Møller, B Hartmann, J Pedersen, JA Windeløv, JJ Holst, H Kissow, GD Pasquale |
PloS one | 2018 |
Diversification of the functions of proglucagon and glucagon receptor genes in fish
DM Irwin, S Mojsov |
General and Comparative Endocrinology | 2018 |
A molecular docking study of Rhizoma Atractylodis and Rhizoma Atractylodis Macrocephalae herbal pair with respect to type 2 diabetes mellitus
C Chen, S Zhou, Q Meng |
Journal of Traditional Chinese Medical Sciences | 2018 |
Pyrrole: An insight into recent pharmacological advances with structure activity relationship
S Ahmad, O Alam, MJ Naim, M Shaquiquzzaman, MM Alam, M Iqbal |
European Journal of Medicinal Chemistry | 2018 |
Blackcurrant Extract Ameliorates Hyperglycemia in Type 2 Diabetic Mice in Association with Increased Basal Secretion of Glucagon-Like Peptide-1 and Activation of AMP-Activated Protein Kinase
Y IIZUKA, A OZEKI, T TANI, T TSUDA |
Journal of Nutritional Science and Vitaminology | 2018 |
Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists
GV Graham, JM Conlon, YH Abdel-Wahab, PR Flatt |
Molecular and Cellular Endocrinology | 2018 |
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
F Bifari, R Manfrini, MD Cas, C Berra, M Siano, M Zuin, R Paroni, F Folli |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2018 |
Peptide-based multi-agonists: a new paradigm in metabolic pharmacology
SJ Brandt, TD Müller, RD DiMarchi, MH Tschöp, K Stemmer |
Journal of Internal Medicine | 2018 |
Relationship between glucagon like peptide-1 and non-alcoholic fatty liver disease in diabetic and non-diabetic patients
N Sheriba, M Samy, C Adel, S Anas |
Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2018 |
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
C Clemmensen, B Finan, TD Müller, RD DiMarchi, MH Tschöp, SM Hofmann |
Nature Reviews Endocrinology | 2018 |
Discovery, characterization and clinical development of the glucagon-like peptides
Daniel Drucker, Joel F. Habener, Jens J. Holst |
Journal of Clinical Investigation | 2017 |
A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion
M Shigeto, CY Cha, P Rorsman, K Kaku |
Journal of Molecular Medicine | 2017 |
The dynamic plasticity of insulin production in β-cells
BB Boland, CJ Rhodes, JS Grimsby |
Molecular Metabolism | 2017 |
The Role of the Autonomic Nervous System in the Pathophysiology of Obesity
D Guarino, M Nannipieri, G Iervasi, S Taddei, RM Bruno |
Frontiers in physiology | 2017 |
Dietary polyunsaturated fatty acids and their metabolites: Implications for diabetes pathophysiology, prevention, and treatment
JC Neuman, RJ Fenske, ME Kimple |
Nutrition and Healthy Aging | 2017 |
The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms
C Zhao, J Liang, Y Yang, M Yu, X Qu |
Frontiers in Endocrinology | 2017 |
Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors
Y Zhang, M Wu, W Htun, EW Dong, F Mauvais-Jarvis, VA Fonseca, H Wu |
Scientific Reports | 2017 |
Venom peptides as pharmacological tools and therapeutics for diabetes
SD Robinson, H Safavi-Hemami |
Neuropharmacology | 2017 |
Obesity and Brain Function
L Letra, R Seiça |
Obesity and Brain Function | 2017 |
Delphinidin 3-rutinoside-rich blackcurrant extract ameliorates glucose tolerance by increasing the release of glucagon-like peptide-1 secretion
T Tani, S Nishikawa, M Kato, T Tsuda |
Food Science & Nutrition | 2017 |
Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice
PK Huang, SX Lin, MJ Tsai, M Leong, SR Lin, R Kankala, CH Lee, CF Weng |
Nanomaterials | 2017 |
Dietary Fiber in Health and Disease
ML Dreher |
Dietary Fiber in Health and Disease | 2017 |
The New Biology and Pharmacology of Glucagon
TD Müller, B Finan, C Clemmensen, RD DiMarchi, MH Tschöp |
Physiological reviews | 2017 |
TEMPORARY REMOVAL: Rebirth of the Incretin Concept: Its conception and early development
V Marks |
Peptides | 2017 |
Suppression of circadian secretion of glucagon-like peptide-1 by the saturated fatty acid, palmitate
A Martchenko, RH Oh, SE Wheeler, P Gurges, JA Chalmers, PL Brubaker |
Acta physiologica (Oxford, England) | 2017 |
Low-molecular fraction of wheat protein hydrolysate stimulates glucagon-like peptide-1 secretion in an enteroendocrine L cell line and improves glucose tolerance in rats
M Kato, T Nakanishi, T Tani, T Tsuda |
Nutrition research (New York, N.Y.) | 2017 |
Evolution of the glucagon-like system across fish
JC Cardoso, RC Félix, C Costa, PF Palma, AV Canário, DM Power |
General and Comparative Endocrinology | 2017 |
GIP („Glucose-Dependent Insulinotropic Polypeptide“) und GLP-1 („Glucagon-Like Petide-1“): Rolle in der Stoffwechselregulation und bei Diabetesmanifestation
D Quast, MA Nauck |
Der Diabetologe | 2017 |
Advances in Beta Cell Replacement and Regeneration Strategies for Treating Diabetes
Jacqueline Benthuysen, Andrea Carrano, Maike Sander |
Journal of Clinical Investigation | 2016 |
The incretin hormone GLP-1 and mechanisms underlying its secretion: Hormone GLP-1 and its secretion
L Tian, T Jin |
Journal of Diabetes | 2016 |
GLP-1 analogue recovers impaired insulin secretion from human islets treated with palmitate via down-regulation of SOCS2
AI Chowdhury, P Bergsten |
Molecular and Cellular Endocrinology | 2016 |
Human G protein-coupled receptor studies in Saccharomyces cerevisiae
R Liu, W Wong, AP IJzerman |
Biochemical Pharmacology | 2016 |
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
C Graaf, D Donnelly, D Wootten, J Lau, PM Sexton, LJ Miller, JM Ahn, J Liao, MM Fletcher, D Yang, AJ Brown, C Zhou, J Deng, MW Wang |
Pharmacological reviews | 2016 |
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology
A Tramutola, A Arena, C Cini, DA Butterfield, E Barone |
Expert Review of Neurotherapeutics | 2016 |
A dual-monoclonal, sandwich immunoassay specific for glucagon like peptide-19–36/7 (GLP-19–36/7)
RI Osborne, W Ming, JS Troutt, RW Siegel, RJ Konrad |
Clinical Biochemistry | 2016 |
Inter-organ communication and regulation of beta cell function
MA Hussain, E Akalestou, W Song |
Diabetologia | 2016 |
The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets
M Ahn, SM Yoder, Z Wang, E Oh, L Ramalingam, R Tunduguru, DC Thurmond |
Diabetologia | 2016 |
GLP-1 mimetic drugs and the risk of exocrine pancreatic disease: Cell and animal studies
JA Williams |
Pancreatology | 2016 |
Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation
E Fernández-Millán, MA Martín, L Goya, E Lizárraga-Mollinedo, F Escrivá, S Ramos, C Álvarez |
Free radical biology & medicine | 2016 |
Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamus
LB Knudsen, A Secher, J Hecksher-Sørensen, C Pyke |
Journal of Diabetes Investigation | 2016 |
Circadian Transcription from Beta Cell Function to Diabetes Pathophysiology.
Perelis M, Ramsey KM, Marcheva B, Bass J |
Journal of Biological Rhythms | 2016 |
Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation
G Torres, PE Morales, M García-Miguel, I Norambuena-Soto, B Cartes-Saavedra, G Vidal-Peña, D Moncada-Ruff, F Sanhueza-Olivares, AS Martín, M Chiong |
Biochemical Pharmacology | 2016 |
Handbook of Lipids in Human Function
GD Pimentel, C Contreras, M López |
Handbook of Lipids in Human Function | 2016 |
Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections
RA Pederson, CH McIntosh |
Journal of Diabetes Investigation | 2016 |
Intra-islet glucagon-like peptide 1
GE Fava, EW Dong, H Wu |
Journal of Diabetes and its Complications | 2016 |
Drug development from the bench to the pharmacy: with special reference to dipeptidyl peptidase - 4 inhibitor development
RD Carr |
Diabetic Medicine | 2016 |
Type II PKAs are anchored to mature insulin secretory granules in INS-1 β-cells and required for cAMP-dependent potentiation of exocytosis
S Villalpando, C Cazevieille, A Fernandez, NJ Lamb, EH Hani |
Biochimie | 2016 |
A new GLP-1 analogue with prolonged glucose-lowering activity in vivo via backbone-based modification at the N-terminus
X Bai, Y Niu, J Zhu, AQ Yang, YF Wu, XS Ye |
Bioorganic & Medicinal Chemistry | 2016 |
The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
F Andreozzi, GA Raciti, C Nigro, GC Mannino, T Procopio, AM Davalli, F Beguinot, G Sesti, C Miele, F Folli |
Journal of Translational Medicine | 2016 |
Histoire des incrétines : Du chien brun au monstre de Gila
JL Schlienger |
Médecine des Maladies Métaboliques | 2016 |
Principles of Diabetes Mellitus
A Ohri, S Vergano, R Bhambri, SH Schneider |
Principles of Diabetes Mellitus | 2016 |
Stereoselective Synthesis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, ( R )-Sitagliptin
R Anjibabu, JM Boggu, P Shekhar, BV Reddy |
ChemistrySelect | 2016 |
Small intestine morphology and recovery after drug-induced colitis in proglucagon-derived peptides knockout mice
M Matsushita, O Watanabe, T Ando, O Maeda, R Miyahara, M Nakamura, T Yamamura, H Goto, Y Hirooka, U Schumacher |
Cogent Medicine | 2016 |
Principles of Endocrinology and Hormone Action
A Belfiore, D LeRoith |
Principles of Endocrinology and Hormone Action | 2016 |
Circadian Transcription from Beta Cell Function to Diabetes Pathophysiology
M Perelis, KM Ramsey, B Marcheva, J Bass |
Journal of Biological Rhythms | 2016 |
Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon
DA Oren, Y Wei, L Skrabanek, BK Chow, T Mommsen, S Mojsov, JL Soengas |
PloS one | 2016 |
Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives
T Jin, J Weng |
American journal of physiology. Endocrinology and metabolism | 2016 |
GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries
C Egholm, MM Khammy, T Dalsgaard, A Mazur, K Tritsaris, AJ Hansen, C Aalkjaer, S Dissing |
American journal of physiology. Heart and circulatory physiology | 2016 |
Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion
M Kato, S Nishikawa, A Ikehata, K Dochi, T Tani, T Takahashi, A Imaizumi, T Tsuda |
Molecular Nutrition & Food Research | 2016 |
cAMP-independent effects of GLP-1 on β cells
Jelena Kolic, Patrick MacDonald |
Journal of Clinical Investigation | 2015 |
Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate ( Macaca mulatta ) Brain
KM Heppner, M Kirigiti, A Secher, SJ Paulsen, R Buckingham, C Pyke, LB Knudsen, N Vrang, KL Grove |
Endocrinology | 2015 |
Deciphering Metabolic Messages From the Gut Drives Therapeutic Innovation: The 2014 Banting Lecture
DJ Drucker |
Diabetes | 2015 |
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
KM Heppner, D Perez-Tilve |
Frontiers in neuroscience | 2015 |
Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice: brain GLP-1 signaling and insulin secretion
E Tudurí, D Beiroa, B Porteiro, M López, C Diéguez, R Nogueiras |
Diabetes Obesity and Metabolism | 2015 |
Epigenetic regulation of the intestinal epithelium
EN Elliott, KH Kaestner |
Cellular and Molecular Life Sciences | 2015 |
Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent Neuron Signaling
CC Ronveaux, D Tome, HE Raybould |
The Journal of nutrition | 2015 |
Vagal mediation of GLP-1's effects on food intake and glycemia
JP Krieger, W Langhans, SJ Lee |
Physiology & Behavior | 2015 |
The Glucagon-Like Peptide-1 Receptor is Present in Pancreatic Acinar Cells and Regulates Amylase Secretion through cyclic AMP
Y Hou, SA Ernst, K Heidenreich, JA Williams |
AJP Gastrointestinal and Liver Physiology | 2015 |
Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells
T Sato, H Hayashi, M Hiratsuka, N Hirasawa |
Molecular and Cellular Endocrinology | 2015 |
Aqueous Fraction of Beta vulgaris Ameliorates Hyperglycemia in Diabetic Mice due to Enhanced Glucose Stimulated Insulin Secretion, Mediated by Acetylcholine and GLP-1, and Elevated Glucose Uptake via Increased Membrane Bound GLUT4 Transporters
AU Kabir, MB Samad, A Ahmed, MR Jahan, F Akhter, J Tasnim, SM Hasan, SS Sayfe, JM Hannan, C Miele |
PloS one | 2015 |
Gastrointestinal hormone research – with a Scandinavian annotation
JF Rehfeld |
Scandinavian Journal of Gastroenterology | 2015 |
Postnatal weight gain induced by overfeeding pups and maternal high-fat diet during the lactation period modulates glucose metabolism and the production of pancreatic and gastrointestinal peptides
Q Du, H Hosoda, T Umekawa, T Kinouchi, N Ito, M Miyazato, K Kangawa, T Ikeda |
Peptides | 2015 |
The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+/Calmodulin-Dependent Kinase II Pathway
M Kato, T Tani, N Terahara, T Tsuda, T Jin |
PloS one | 2015 |
Glucose-dependent insulinotropic polypeptide directly induces glucose transport in rat skeletal muscle
LA Snook, EM Nelson, DJ Dyck, DC Wright, GP Holloway |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2015 |
Ghrelin regulates GLP-1 production through mTOR signaling in L cells
G Xu, X Hong, H Tang, S Jiang, F Liu, Z Shen, Z Li, W Zhang |
Molecular and Cellular Endocrinology | 2015 |
Clinical use of GLP-1 agonists and DPP4 inhibitors
BE Tuch |
Pancreatology | 2015 |
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
DA Sandoval, DA D'Alessio |
Physiological reviews | 2015 |
Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
M Romaní-Pérez, V Outeiriño-Iglesias, CM Moya, P Santisteban, LC González-Matías, E Vigo, F Mallo |
Endocrinology | 2015 |
Gluco-incretins regulate Beta-cell glucose competence by epigenetic silencing of fxyd3 expression
D Vallois, G Niederhäuser, M Ibberson, V Nagaray, L Marselli, P Marchetti, JY Chatton, B Thorens |
PloS one | 2014 |
GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
D Beiroa, M Imbernon, R Gallego, A Senra, D Herranz, F Villarroya, M Serrano, J Ferno, J Salvador, J Escalada, C Dieguez, M Lopez, G Fruhbeck, R Nogueiras |
Diabetes | 2014 |
Molecular dynamic simulations reveal the mechanism of binding between xanthine inhibitors and DPP-4
Y Gu, W Wang, X Zhu, K Dong |
Journal of Molecular Modeling | 2014 |
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation: Molecular physiology of GLP-1R
K Pabreja, MA Mohd, C Koole, D Wootten, SG Furness |
British Journal of Pharmacology | 2014 |
Cardiovascular and hemodynamic effects of glucagon-like peptide-1
AG Goodwill, KJ Mather, AM Conteh, DJ Sassoon, JN Noblet, JD Tune |
Reviews in Endocrine and Metabolic Disorders | 2014 |
Regulation of glucose homeostasis by GLP-1
P Nadkarni, OG Chepurny, GG Holz |
Progress in molecular biology and translational science | 2014 |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease | 2014 |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease | 2014 |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease | 2014 |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease | 2014 |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease | 2014 |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan |
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease | 2014 |
Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat
M López, C Diéguez, R Nogueiras |
Adipocyte | 2014 |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women
SK Hegazy |
Journal of Bone and Mineral Metabolism | 2014 |
Evaluation of Intragastric Vs Intraperitoneal Glucose Tolerance Tests in the Evaluation of Insulin Resistance in a Rodent Model of Burn Injury and Glucagon-Like Polypeptide-1 Treatment:
S Watada, YM Yu, AJ Fischman, T Kurihara, C Shen, RG Tompkins, S Fagan |
Journal of Burn Care & Research | 2014 |
Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats
K Tanaka, Y Masaki, M Tanaka, M Miyazaki, M Enjoji, M Nakamuta, M Kato, M Nomura, T Inoguchi, K Kotoh, R Takayanagi |
World journal of gastroenterology : WJG | 2014 |
Polyphenols in Human Health and Disease
BK Tan, KW Ong |
Polyphenols in Human Health and Disease | 2014 |
Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report
FK Knop, A Lund, S Madsbad, JJ Holst, T Krarup, T Vilsbøll |
BMC Research Notes | 2014 |
Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells
ZQ Zhu, D Wang, D Xiang, YX Yuan, Y Wang |
Metabolism | 2014 |
Effects of sitagliptin on plasma incretin concentrations after glucose administration through an esophagostomy tube or feeding in healthy cats
N Nishii, S Takashima, A Iguchi, Y Murahata, A Matsuu, Y Hikasa, H Kitagawa |
Domestic Animal Endocrinology | 2014 |
GLP-1-related proteins attenuate the effects of mitochondrial membrane damage in pancreatic β cells
M Ogata, N Iwasaki, R Ide, M Takizawa, Y Uchigata |
Biochemical and Biophysical Research Communications | 2014 |
Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
X Ji, M Su, J Wang, G Deng, S Deng, Z Li, C Tang, J Li, J Li, L Zhao, H Jiang, H Liu |
European Journal of Medicinal Chemistry | 2014 |
Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents: GLP-1 Prevents Inflammation-Induced Dysfunction
T Iwai, T Sawabe, K Tanimitsu, M Suzuki, S Sasaki-Hamada, JI Oka |
Journal of Neuroscience Research | 2014 |
Should we still be concerned about the potential side effects of glucagon-like peptide-1 receptor agonists on thyroid C cells?
Y Cao, XM Liu |
Endocrine | 2014 |
GLP-1: The Oracle for Gastric Bypass?
G Fruhbeck, R Nogueiras |
Diabetes | 2014 |
Design, Synthesis, Biological Screening, and Molecular Docking Studies of Piperazine-Derived Constrained Inhibitors of DPP-IV for the Treatment of Type 2 Diabetes
RN Kushwaha, R Srivastava, A Mishra, AK Rawat, AK Srivastava, W Haq, SB Katti |
Chemical Biology & Drug Design | 2014 |
Amelioration of Glycemic Control by Sleeve Gastrectomy and Gastric Bypass in a Lean Animal Model of Type 2 Diabetes: Restoration of Gut Hormone Profile
H Eickhoff, TM Louro, PN Matafome, F Vasconcelos, RM Seiça, FC Sousa |
Obesity Surgery | 2014 |
Insulin Secretion Induced by Glucose-dependent Insulinotropic Polypeptide Requires Phosphatidylinositol 3-Kinase in Rodent and Human -Cells
J Kolic, AF Spigelman, AM Smith, JE Fox, PE MacDonald |
The Journal of biological chemistry | 2014 |
Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
X Ji, C Xia, J Wang, M Su, L Zhang, T Dong, Z Li, X Wan, J Li, J Li, L Zhao, Z Gao, H Jiang, H Liu |
European Journal of Medicinal Chemistry | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Islets of Langerhans, 2. ed
MS Islam |
Islets of Langerhans, 2. ed. | 2014 |
Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor
K Tatarkiewicz, EJ Sablan, CJ Polizzi, C Villescaz, DG Parkes |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2014 |
Islets of Langerhans
S Islam |
2014 | |
Amelioration of Glycemic Control by Sleeve Gastrectomy and Gastric Bypass in a Lean Animal Model of Type 2 Diabetes: Restoration of Gut Hormone Profile
H Eickhoff, TM Louro, PN Matafome, F Vasconcelos, RM Seiça, FC e Sousa |
Obesity Surgery | 2014 |
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism
E Ceccarelli, EG Guarino, D Merlotti, A Patti, L Gennari, R Nuti, F Dotta |
Frontiers in Endocrinology | 2013 |
Pulmonary GLP-1 Receptor Increases at Birth and Exogenous GLP-1 Receptor Agonists Augmented Surfactant-Protein Levels in Litters From Normal and Nitrofen-Treated Pregnant Rats
M Romaní-Pérez, V Outeiriño-Iglesias, M Gil-Lozano, LC González-Matías, F Mallo, E Vigo |
Endocrinology | 2013 |
AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration
K Tajima, J Shirakawa, Y Togashi, H Inoue, K Sato, K Orime, Y Ito, M Kaji, E Sakamoto, A Nakamura, K Aoki, Y Goshima, T Atsumi, Y Terauchi, N Irwin |
PloS one | 2013 |
Impact of intestinal electrical stimulation on nutrient-induced GLP-1 secretion in vivo
D Sandoval, A Dunki-Jacobs, J Sorrell, RJ Seeley, DD D'Alessio |
Neurogastroenterology & Motility | 2013 |
Exendin (5-39), an antagonist of GLP-1 receptor, modulates synaptic transmission via glutamate uptake in the dentate gyrus
K Kobayashi, T Iwai, S Sasaki-Hamada, G Kamanaka, JI Oka |
Brain Research | 2013 |
Functional characterization of Cdkal1, a risk factor of type 2 diabetes, and the translational opportunities
S Watanabe, FY Wei, K Tomizawa |
Drug Discovery Today: Disease Models | 2013 |
Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication
G Gu, B Roland, K Tomaselli, CS Dolman, C Lowe, JS Heilig |
The Journal of Comparative Neurology | 2013 |
Design and Synthesis of 4-(2,4,5-Trifluorophenyl)butane-1,3-diamines as Dipeptidyl Peptidase IV Inhibitors
L Zhu, Y Li, L Qiu, M Su, X Wang, C Xia, Y Qu, J Li, J Li, B Xiong, J Shen |
ChemMedChem | 2013 |
Activin A, exendin-4, and glucose stimulate differentiation of human pancreatic ductal cells
HS Kim, SH Hong, SH Oh, JH Kim, MS Lee, MK Lee |
Journal of Endocrinology | 2013 |
The required beta cell research for improving treatment of type 2 diabetes
B Thorens |
Journal of Internal Medicine | 2013 |
A novel glucagon-like peptide 1 peptide identified from Ophisaurus harti: A NOVEL GLP1 PEPTIDE IDENTIFIED FROM O. HARTI
J Zhu, X Huang, H Gao, Q Bao, Y Zhao, JF Hu, G Xia |
Journal of Peptide Science | 2013 |
Glucagon-like peptide-1: modulator of β -cell dysfunction and death
D Rondas, W D'Hertog, L Overbergh, C Mathieu |
Diabetes, Obesity and Metabolism | 2013 |
The modulatory role of high fat feeding on gastrointestinal signals in obesity
FA Duca, Y Sakar, M Covasa |
The Journal of Nutritional Biochemistry | 2013 |
Resistin regulates pituitary lipid metabolism and inflammation in vivo and in vitro
F Rodriguez-Pacheco, MG Novelle, MJ Vazquez, E Garcia-Escobar, F Soriguer, G Rojo-Martinez, E García-Fuentes, MM Malagon, C Dieguez |
Mediators of Inflammation | 2013 |
Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER
V Gigoux, D Fourmy |
Frontiers in Endocrinology | 2013 |
Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes: Research Letter
Y Nagai, E Hashimoto, R Oikawa, S Asai, Y Terashima, Y Nakamura, Y Sasaki, H Tsukiyama, H Fukuda, T Ohshige, H Kato, A Ohta, Y Tanaka |
Diabetes Obesity and Metabolism | 2013 |
Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials (胰高血糖素样肽-1受体激动剂的使用与骨折的关系:一项对随机临床试验的meta分析): GLP-1Ra and bone fractures
G Mabilleau, A Mieczkowska, D Chappard |
Journal of Diabetes | 2013 |
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
L Bloemendaal, JS Kulve, SE la Fleur, RG Ijzerman, M Diamant |
Journal of Endocrinology | 2013 |
Cardiovascular Effects of Incretins in Diabetes
A Advani, A Bugyei-Twum, KA Connelly |
Canadian Journal of Diabetes | 2013 |
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering
AN Hegde |
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering | 2013 |
An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
A Puddu, F Mach, A Nencioni, GL Viviani, F Montecucco |
Mediators of Inflammation | 2013 |
GLP-1-derived nonapeptide GLP-1(28–36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice
W Ip, W Shao, YA Chiang, T Jin |
American journal of physiology. Endocrinology and metabolism | 2013 |
Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
CM Edwards |
BRIT J HOSP MED | 2013 |
Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
JH Ellenbroek, HA Töns, MJ van Meeteren, N de Graaf, MA Hanegraaf, TJ Rabelink, F Carlotti, EJ de Koning |
Diabetologia | 2013 |
Glucagon-Like Peptide-1 and its Cardiovascular Effects
KS Heo, K Fujiwara, J Abe |
Current Atherosclerosis Reports | 2012 |
Cardiovascular Biology of the Incretin System
JR Ussher, DJ Drucker |
Endocrine reviews | 2012 |
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
FS Willard, KW Sloop |
Experimental Diabetes Research | 2012 |
Glucagon secretion and signaling in the development of diabetes
HY Gaisano, PE Macdonald, M Vranic |
Frontiers in physiology | 2012 |
Possible Role of GLP-1 and Its Agonists in the Treatment of Type 1 Diabetes Mellitus
CM Issa, ST Azar |
Current Diabetes Reports | 2012 |
Functional importance of GLP-1 receptor species and expression levels in cell lines
LB Knudsen, S Hastrup, CR Underwood, BS Wulff, J Fleckner |
Regulatory Peptides | 2012 |
Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity
FA Duca, M Covasa |
British Journal of Nutrition | 2012 |
Targeting the glucagon receptor family for diabetes and obesity therapy
YM Cho, CE Merchant, TJ Kieffer |
Pharmacology & Therapeutics | 2012 |
Biophysical and Pharmacological Properties of Glucagon-Like Peptide-1 in Rats Under Isoflurane Anesthesia:
T Kawano, K Tanaka, H Chi, S Eguchi, F Yamazaki, S Kitamura, N Kumagai, M Yokoyama |
Anesthesia & Analgesia | 2012 |
Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity
KS Panickar |
Molecular Nutrition & Food Research | 2012 |
The structure and function of the glucagon-like peptide-1 receptor and its ligands
D Donnelly |
British Journal of Pharmacology | 2012 |
A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer
WY Chiu, SR Shih, CH Tseng |
Experimental Diabetes Research | 2012 |
The Anorectic Effect of GLP-1 in Rats Is Nutrient Dependent
D Sandoval, JG Barrera, MA Stefater, S Sisley, SC Woods, DD DAlessio, RJ Seeley, A Siegel |
PloS one | 2012 |
Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms
J Zhang, RC Ritter |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2012 |
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro
S Baldassano, GD Wang, F Mulè, JD Wood |
AJP Gastrointestinal and Liver Physiology | 2012 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Hypothalamic control of energy and glucose metabolism
S Sisley, D Sandoval |
Reviews in Endocrine and Metabolic Disorders | 2011 |
GLP-1, the gut-brain, and brain-periphery axes
C Cabou, R Burcelin |
The review of diabetic studies : RDS | 2011 |
Absence of the Glucagon-Like Peptide-1 Receptor Does Not Affect the Metabolic Phenotype of Mice with Liver-Specific Gsα Deficiency
M Chen, E Mema, J Kelleher, N Nemechek, A Berger, J Wang, T Xie, O Gavrilova, DJ Drucker, LS Weinstein |
Endocrinology | 2011 |
Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus
M Dharmalingam, U Sriram, MP Baruah |
Indian journal of endocrinology and metabolism | 2011 |
The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
M Shimoda, Y Kanda, S Hamamoto, K Tawaramoto, M Hashiramoto, M Matsuki, K Kaku |
Diabetologia | 2011 |
Fish Physiology
NR Bury, D Boyle, CA Cooper |
Homeostasis and Toxicology of Essential Metals | 2011 |
The emerging role of the intestine in metabolic diseases
WD Bradley, C Zwingelstein, CM Rondinone |
Archives Of Physiology And Biochemistry | 2011 |
Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota
TD Swartz, FA Duca, T Wouters, Y Sakar, M Covasa |
British Journal of Nutrition | 2011 |
Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes
M Jean, M Alameh, MD Buschmann, A Merzouki |
Gene Therapy | 2011 |
Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125
Y Miyamoto, Y Banno, T Yamashita, T Fujimoto, S Oi, Y Moritoh, T Asakawa, O Kataoka, K Takeuchi, N Suzuki, K Ikedo, T Kosaka, S Tsubotani, A Tani, M Funami, M Amano, Y Yamamoto, K Aertgeerts, J Yano, H Maezaki |
Bioorganic & Medicinal Chemistry | 2011 |
Reprogramming gut and pancreas endocrine cells to treat diabetes
E Tudurí, TJ Kieffer |
Diabetes, Obesity and Metabolism | 2011 |
Processing of proglucagon to GLP-1 in pancreatic -cells: is this a paracrine mechanism enabling GLP-1 to act on -cells?
NM Whalley, LE Pritchard, DM Smith, A White |
Journal of Endocrinology | 2011 |
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus
M Hillman, L Eriksson, L Mared, K Helgesson, M Landin-Olsson |
Journal of Cystic Fibrosis | 2011 |
DPP-4 inhibitors in the treatment of type 2 diabetes
H Duez, B Cariou, B Staels |
Biochemical Pharmacology | 2011 |
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick |
Williams Textbook of Endocrinology | 2011 |
Update on incretin hormones : Update on incretin hormones
LK Phillips, JB Prins |
Annals of the New York Academy of Sciences | 2011 |
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro
S Baldassano, GD Wang, F Mulè, JD Wood |
American journal of physiology. Gastrointestinal and liver physiology | 2011 |
Dynamics of plasma active GLP-1 versus insulin and glucose concentrations during GLP-1 infusion in rat model of postprandial hyperglycemia
J Eiki, T Yada |
Endocrine Journal | 2011 |
A High-Fat, High-Fructose Diet Accelerates Nutrient Absorption and Impairs Net Hepatic Glucose Uptake in Response to a Mixed Meal in Partially Pancreatectomized Dogs
KC Coate, G Kraft, M Lautz, M Smith, DW Neal, AD Cherrington |
The Journal of nutrition | 2011 |
Handbook of Behavior, Food and Nutrition
VR Preedy, RR Watson, CR Martin |
2011 | |
Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell
AJ Mulherin, AH Oh, H Kim, A Grieco, LM Lauffer, PL Brubaker |
Endocrinology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
GIP: No Longer the Neglected Incretin Twin?
RN Kulkarni |
Science Translational Medicine | 2010 |
Type 2 Diabetes: An Expanded View of Pathophysiology and Therapy
J Unger, CG Parkin |
Postgraduate Medicine | 2010 |
Burger's Medicinal Chemistry and Drug Discovery
S Bruno, L Ronda, S Faggiano, S Bettati, A Mozzarelli |
Burger's Medicinal Chemistry and Drug Discovery | 2010 |
Textbook of Diabetes
PM Jones, SJ Persaud |
Textbook of Diabetes | 2010 |
Analogue-Based Drug Discovery II
J Fischer, CR Ganellin, A Ganesan, J Proudfoot |
Analogue-Based Drug Discovery II | 2010 |
Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals
T Nakamori |
Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals | 2010 |
Incretins: clinical perspectives, relevance, and applications for the primary care physician in the treatment of patients with type 2 diabetes mellitus
J Unger |
Mayo Clinic proceedings. Mayo Clinic | 2010 |
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
BL Furman |
Toxicon | 2010 |
Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
BP Cummings, KL Stanhope, JL Graham, DG Baskin, SC Griffen, C Nilsson, A Sams, LB Knudsen, K Raun, PJ Havel |
Diabetes | 2010 |
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets
KW Sloop, FS Willard, MB Brenner, J Ficorilli, K Valasek, AD Showalter, TB Farb, JX Cao, AL Cox, MD Michael, SM Sanfeliciano, MJ Tebbe, MJ Coghlan |
Diabetes | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
The Physiology of Glucagon
GJ Taborsky |
Journal of diabetes science and technology | 2010 |
Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM
GG Kelley, OG Chepurny, F Schwede, HG Genieser, CA Leech, MW Roe, X Li, I Dzhura, E Dzhura, P Afshari, GG Holz |
Islets | 2010 |
Treatment of diabetes with glucagon-like peptide-1 gene therapy
MJ Riedel, TJ Kieffer |
Expert Opinion on Biological Therapy | 2010 |
Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal
L Yang, X Li, Y Ji, AB Kohan, DQ Wang, PN Howles, DY Hui, J Lai, P Tso |
AJP Gastrointestinal and Liver Physiology | 2010 |
Odyssey between Scylla and Charybdis through storms of carbohydrate metabolism and diabetes: a career retrospective
M Vranic |
American journal of physiology. Endocrinology and metabolism | 2010 |
Structure, Function, and Regulation of Insulin-Degrading Enzyme
RE Hulse, LA Ralat, WJ Tang |
Vitamins and hormones | 2009 |
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard |
2009 | |
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard |
2009 | |
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard |
2009 | |
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard |
2009 | |
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard |
2009 | |
Ca v 1.2 and Ca v 1.3 Are Differentially Coupled to Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion in the Pancreatic β-Cell Line INS-1
SM Jacobo, ML Guerra, GH Hockerman |
The Journal of pharmacology and experimental therapeutics | 2009 |
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
R Abu-Hamdah, A Rabiee, GS Meneilly, RP Shannon, DK Andersen, D Elahi |
The Journal of clinical endocrinology and metabolism | 2009 |
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard |
2009 | |
Pax6 Haploinsufficiency Causes Abnormal Metabolic Homeostasis by Down-Regulating Glucagon-Like Peptide 1 in Mice
J Ding, Y Gao, J Zhao, H Yan, S Guo, Q Zhang, L Li, X Gao |
Endocrinology | 2009 |
Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue
K Retterstøl |
Expert Opinion on Investigational Drugs | 2009 |
Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP
R Mentlein |
Best Practice & Research Clinical Endocrinology & Metabolism | 2009 |
Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity
H Ghanaat-Pour, Å Sjöholm |
Diabetes/Metabolism Research and Reviews | 2009 |
Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM
GG Kelley, OG Chepurny, F Schwede, HG Genieser, CA Leech, MW Roe, X Li, I Dzhura, E Dzhura, P Afshari, GG Holz |
Islets | 2009 |
The influences of juvenile diabetes on memory and hippocampal plasticity in rats: Improving effects of glucagon-like peptide-1
T Iwai, M Suzuki, K Kobayashi, K Mori, Y Mogi, JI Oka |
Neuroscience Research | 2009 |
Appropriate, timely, and rational treatment of type 2 diabetes mellitus: Meeting the challenges of primary care
J Unger, CG Parkin |
Insulin | 2009 |
Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity
C Mapelli, SI Natarajan, JP Meyer, MM Bastos, MS Bernatowicz, VG Lee, J Pluscec, DJ Riexinger, ES Sieber-McMaster, KL Constantine, CA Smith-Monroy, R Golla, Z Ma, DA Longhi, D Shi, L Xin, JR Taylor, B Koplowitz, CL Chi, A Khanna, GW Robinson, R Seethala, IA Antal-Zimanyi, RH Stoffel, S Han, JM Whaley, CS Huang, J Krupinski, WR Ewing |
Journal of Medicinal Chemistry | 2009 |
Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake
DA Sandoval, D Bagnol, SC Woods, DA D'Alessio, RJ Seeley |
Diabetes | 2008 |
CNS GLP-1 regulation of peripheral glucose homeostasis
D Sandoval |
Physiology & Behavior | 2008 |
Transplantation of PC1/3-Expressing α-cells Improves Glucose Handling and Cold Tolerance in Leptin-resistant Mice
RD Wideman, SL Gray, SD Covey, GC Webb, TJ Kieffer |
Molecular Therapy | 2008 |
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications
S Onoue, S Misaka, S Yamada |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2008 |
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
hellström, näslund, edholm, schmidt, kristensen, theodorsson, holst, efendic |
Neurogastroenterology & Motility | 2008 |
Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol
A Gangemi, P Salehi, B Hatipoglu, J Martellotto, B Barbaro, JB Kuechle, M Qi, Y Wang, P Pallan, C Owens, J Bui, D West, B Kaplan, E Benedetti, J Oberholzer |
American Journal of Transplantation | 2008 |
The Use of Exenatide in Islet Transplant Recipients with Chronic Allograft Dysfunction: Safety, Efficacy, and Metabolic Effects
T Froud, RN Faradji, A Pileggi, S Messinger, DA Baidal, GM Ponte, PE Cure, K Monroy, A Mendez, G Selvaggi, C Ricordi, R Alejandro |
Transplantation | 2008 |
Handbook of Prebiotics
F Guarner |
Handbook of Prebiotics | 2008 |
ROLE OF BRAIN PROSTANOIDS IN GLUCAGON-LIKE PEPTIDE-1-INDUCED CENTRAL ACTIVATION OF SYMPATHO-ADRENOMEDULLARY OUTFLOW IN RATS
J Arai, S Okada, N Yamaguchi-shima, T Shimizu, T Sasaki, M Yorimitsu, H Wakiguchi, K Yokotani |
Clinical and Experimental Pharmacology and Physiology | 2008 |
The physiology and pharmacology of incretins in type 2 diabetes mellitus
JJ Holst |
Diabetes, Obesity and Metabolism | 2008 |
Upregulation of the brainstem preproglucagon system in the obese Zucker rat
N Vrang, PJ Larsen, PB Jensen, K Lykkegaard, A Artmann, LK Larsen, M Tang-Christensen |
Brain Research | 2008 |
Low, but Physiological, Concentration of GLP-1 Stimulates Insulin Secretion Independent of the cAMP-Dependent Protein Kinase Pathway
M Shigeto, M Katsura, M Matsuda, S Ohkuma, K Kaku |
Journal of Pharmacological Sciences | 2008 |
Dietary Fiber in the Prevention and Treatment of Metabolic Syndrome: A Review
A Aleixandre, M Miguel |
Critical Reviews in Food Science and Nutrition | 2008 |
The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions
J Girard |
Diabetes & Metabolism | 2008 |
GLP-1 et système nerveux : un mécanisme de son action antidiabétique
R Burcelin, M Massebœuf, C Cabou |
Médecine des Maladies Métaboliques | 2008 |
Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice
H Su, M He, H Li, Q Liu, J Wang, Y Wang, W Gao, L Zhou, J Liao, AA Young, MW Wang, HH Schmidt |
PloS one | 2008 |
Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation
Z Liu, JF Habener |
The Journal of biological chemistry | 2008 |
Beyond Glycemic Control
CL Martin |
The Diabetes Educator | 2008 |
Insulin as a physiological modulator of glucagon secretion
P Bansal, Q Wang |
American journal of physiology. Endocrinology and metabolism | 2008 |
Managing the β-cell with GLP-1 in type 2 diabetes
B Gallwitz |
The British Journal of Diabetes & Vascular Disease | 2008 |
Pancreatic Beta Cell in Health and Disease
S Seino, GI Bell |
2008 | |
GPR119: “Double-Dipping” for Better Glycemic Control
L Lauffer, R Iakoubov, PL Brubaker |
Endocrinology | 2008 |
Identification of Glucose-Dependent Insulin Secretion Targets in Pancreatic β Cells by Combining Defined-Mechanism Compound Library Screening and siRNA Gene Silencing
W Wu, J Shang, Y Feng, CM Thompson, S Horwitz, JR Thompson, ED Macintyre, NA Thornberry, K Chapman, YP Zhou, AD Howard, J Li |
Journal of biomolecular screening | 2008 |
Intestinal Regulation of Glucose
Daniel J. Drucker |
Journal of Clinical Investigation | 2007 |
Mechanisms of action of glucagon-like peptide 1 in the pancreas
ME Doyle, JM Egan |
Pharmacology & Therapeutics | 2007 |
Dendritic cell–expanded, islet-specific CD4 + CD25 + CD62L + regulatory T cells restore normoglycemia in diabetic NOD mice
KV Tarbell, L Petit, X Zuo, P Toy, X Luo, A Mqadmi, H Yang, M Suthanthiran, S Mojsov, RM Steinman |
Journal of Experimental Medicine | 2007 |
Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug
I Idris, R Donnelly |
Diabetes, Obesity and Metabolism | 2007 |
Biology of Incretins: GLP-1 and GIP
LL Baggio, DJ Drucker |
Gastroenterology | 2007 |
Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes
RE Pratley, A Salsali |
Current Medical Research and Opinion | 2007 |
A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice
D Chen, J Liao, N Li, C Zhou, Q Liu, G Wang, R Zhang, S Zhang, L Lin, K Chen, X Xie, F Nan, AA Young, MW Wang |
Proceedings of the National Academy of Sciences | 2007 |
Effect of glucagon-like peptide-1 and -2 on regulation of food intake, body temperature and locomotor activity in the Japanese quail
S Shousha, K Nakahara, T Nasu, T Sakamoto, N Murakami |
Neuroscience Letters | 2007 |
Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats
Y Nakade, K Tsukamoto, M Iwa, TN Pappas, T Takahashi |
Autonomic Neuroscience | 2007 |
Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia: Possible Contribution to Impaired Incretin Effects in Diabetes
G Xu, H Kaneto, DR Laybutt, VF Duvivier-Kali, N Trivedi, K Suzuma, GL King, GC Weir, S Bonner-Weir |
Diabetes | 2007 |
Quantitative trait loci for carbohydrate and total energy intake on mouse chromosome 17: congenic strain confirmation and candidate gene analyses ( Glo1 , Glp1r )
KG Kumar, AC Poole, B York, J Volaufova, A Zuberi, BK Richards |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2007 |
The Physiology of Glucagon-like Peptide 1
JJ Holst |
Physiological reviews | 2007 |
Diabetes: Rationale for Dipeptidyl Peptidase 4 Inhibitors: A New Class of Oral Agents for the Treatment of Type 2 Diabetes Mellitus
RK Campbell |
The Annals of pharmacotherapy | 2007 |
Glucagon-like peptide-1 stimulates GABA formation by pancreatic β-cells at the level of glutamate decarboxylase
C Wang, R Mao, MV de Casteele, D Pipeleers, Z Ling |
American journal of physiology. Endocrinology and metabolism | 2007 |
Pharmacotherapy of Diabetes: New Developments
CE Mogensen |
2007 | |
Discovery and Structure−Activity Relationships of Piperidinone- and Piperidine-Constrained Phenethylamines as Novel, Potent, and Selective Dipeptidyl Peptidase IV Inhibitors
Z Pei, X Li, TW von Geldern, K Longenecker, D Pireh, KD Stewart, BJ Backes, C Lai, TH Lubben, SJ Ballaron, DW Beno, AJ Kempf-Grote, HL Sham, JM Trevillyan |
Journal of Medicinal Chemistry | 2007 |
Gastrointestinal hormones regulating appetite
O Chaudhri, C Small, S Bloom |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2006 |
Major contributions of comparative endocrinology to the development and exploitation of the incretin concept
JM Conlon, S Patterson, PR Flatt |
Journal of Experimental Zoology Part A: Comparative Experimental Biology | 2006 |
Gut?Brain Axis: Regulation of Glucose Metabolism
AC Heijboer, H Pijl, AM van Hoek, LM Havekes, JA Romijn, EP Corssmit |
Journal of Neuroendocrinology | 2006 |
Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005
JJ Holst |
Diabetologia | 2006 |
Glucagon-Like Peptide-2: Update of the Recent Clinical Trials
PB Jeppesen |
Gastroenterology | 2006 |
Newer therapeutic options for children with diabetes mellitus: theoretical and practical considerations
GS Jeha, RA Heptulla |
Pediatric Diabetes | 2006 |
Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures
CM Mack, CX Moore, CM Jodka, S Bhavsar, JK Wilson, JA Hoyt, JL Roan, C Vu, KD Laugero, DG Parkes, AA Young |
International Journal of Obesity | 2006 |
“The next big thing” in diabetes: clinical progress on DPP-IV inhibitors
TW von Geldern, JM Trevillyan |
Drug Development Research | 2006 |
Increased insulin resistance and β cell activity in patients with Crohn's disease
N Bregenzer, A Hartmann, U Strauch, J Schölmerich, T Andus, LC Bollheimer |
Inflammatory Bowel Diseases | 2006 |
Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1)
RD Wideman, IL Yu, TD Webber, CB Verchere, JD Johnson, AT Cheung, TJ Kieffer |
Proceedings of the National Academy of Sciences | 2006 |
GLP-1 based therapy for type 2 diabetes
DK Arulmozhi, B Portha |
European Journal of Pharmaceutical Sciences | 2006 |
Using Evolutionary Information and Ancestral Sequences to Understand the Sequence–Function Relationship in GLP-1 Agonists
M Skovgaard, JT Kodra, DX Gram, SM Knudsen, D Madsen, DA Liberles |
Journal of Molecular Biology | 2006 |
Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin
T Adachi, T Tanaka, K Takemoto, T Koshimizu, A Hirasawa, G Tsujimoto |
Biochemical and Biophysical Research Communications | 2006 |
Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not
K Raun, P Voss, CF Gotfredsen, V Golozoubova, B Rolin, LB Knudsen |
Diabetes | 2006 |
Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide
Y Yamada, K Miyawaki, K Tsukiyama, N Harada, C Yamada, Y Seino |
Diabetes | 2006 |
Physiology of the Gastrointestinal Tract
DJ Drucker |
Physiology of the Gastrointestinal Tract | 2006 |
Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action
V Ionut, IF Liberty, K Hucking, M Lottati, D Stefanovski, D Zheng, RN Bergman |
American journal of physiology. Endocrinology and metabolism | 2006 |
Discovery, Structure−Activity Relationship, and Pharmacological Evaluation of (5-Substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as Potent Dipeptidyl Peptidase IV Inhibitors
Z Pei, X Li, K Longenecker, TW von Geldern, PE Wiedeman, TH Lubben, BA Zinker, K Stewart, SJ Ballaron, MA Stashko, AK Mika, DW Beno, M Long, H Wells, AJ Kempf-Grote, DJ Madar, TS McDermott, L Bhagavatula, MG Fickes, D Pireh, LR Solomon, MR Lake, R Edalji, EH Fry, HL Sham, JM Trevillyan |
Journal of Medicinal Chemistry | 2006 |
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
MJ Theodorakis, O Carlson, S Michopoulos, ME Doyle, M Juhaszova, K Petraki, JM Egan |
American journal of physiology. Endocrinology and metabolism | 2005 |
Prevalence, predisposition and prevention of type II diabetes
D Cheng |
Nutrition & Metabolism | 2005 |
A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome
H Yamamoto, T Mori, H Tsuchihashi, H Akabori, H Naito, T Tani |
Digestive Diseases and Sciences | 2005 |
Significance of Prohormone Convertase 2, PC2, Mediated Initial Cleavage at the Proglucagon Interdomain Site, Lys70-Arg71, to Generate Glucagon
A Dey, GM Lipkind, Y Rouillé, C Norrbom, J Stein, C Zhang, R Carroll, DF Steiner |
Endocrinology | 2005 |
Alpha cell function in health and disease: influence of glucagon-like peptide-1
BE Dunning, JE Foley, B Ahrén |
Diabetologia | 2005 |
The incretins: a link between nutrients and well-being
R Burcelin |
British Journal of Nutrition | 2005 |
The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management
OA Roges, M Baron, A Philis-Tsimikas |
Expert Opinion on Investigational Drugs | 2005 |
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier, MA Nauck |
Diabetes/Metabolism Research and Reviews | 2005 |
Exenatide: a novel treatment of Type 2 diabetes
B Ahren |
Therapy | 2005 |
Gastrointestinal Physiology
WC Orr |
Principles and Practice of Sleep Medicine | 2005 |
The [pre-] history of the incretin concept
W Creutzfeldt |
Regulatory Peptides | 2005 |
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
T Hansotia, DJ Drucker |
Regulatory Peptides | 2005 |
Glucagon-like peptide 1 and its derivatives in the treatment of diabetes
MA Nauck, JJ Meier |
Regulatory Peptides | 2005 |
Dipeptidyl peptidase IV inhibitors for type 2 diabetes and metabolic syndrome
PE Wiedeman, JM Trevillyan |
Drug Discovery Today: Therapeutic Strategies | 2005 |
Gluco-Incretins Control Insulin Secretion at Multiple levels As Revealed In Mice Lacking GLP-1 And GIP Receptors
Frédéric Preitner, Mark Ibberson, Isobel Franklin, Christophe Binnert, Mario Pende, Asllan Gjinovci, Tanya Hansotia, Daniel J. Drucker, Claes Wollheim, Rémy Burcelin, Bernard Thorens |
Journal of Clinical Investigation | 2004 |
Targeting β-cell cyclic 3′5′adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review
B Furman, N Pyne, P Flatt, F O'Harte |
Journal of Pharmacy and Pharmacology | 2004 |
Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects
E Näslund, N King, S Mansten, N Adner, JJ Holst, M Gutniak, PM Hellström |
British Journal of Nutrition | 2004 |
Gut peptides in the treatment of diabetes mellitus
TP Vahl, DA D’Alessio |
Expert Opinion on Investigational Drugs | 2004 |
Glucagon-like peptide-1 and glucagon-like peptide-2
LL Baggio, DJ Drucker |
Best Practice & Research Clinical Endocrinology & Metabolism | 2004 |
Islet replacement vs. regeneration: Hope or hype?
V Ramiya, D Schatz |
Pediatric Diabetes | 2004 |
New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells
GG Holz, G Holz |
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme | 2004 |
Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?
CF Deacon, B Ahrén, JJ Holst |
Expert Opinion on Investigational Drugs | 2004 |
Aminomethylpyridines as DPP-IV inhibitors
JU Peters, S Weber, S Kritter, P Weiss, A Wallier, D Zimmerli, M Boehringer, M Steger, BM Loeffler |
Bioorganic & Medicinal Chemistry Letters | 2004 |
Gastro-intestinal hormones GIP and GLP-1
TJ Kieffer |
Annales d'Endocrinologie | 2004 |
Fish proglucagon genes have differing coding potential
L Zhou, DM Irwin |
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology | 2004 |
Mechanisms of glucose sensing and multiplicity of glucose sensors
B Thorens |
Annales d'Endocrinologie | 2004 |
Identification and Characterization of a Glucagon Receptor from the Goldfish Carassius auratus: Implications for the Evolution of the Ligand Specificity of Glucagon Receptors in Vertebrates
BK Chow, TW Moon, RL Hoo, CM Yeung, M Müller, PJ Christos, S Mojsov |
Endocrinology | 2004 |
Glucose-dependent insulinotropic polypeptide: its role in glucose and lipid homeostasis
CC Tseng |
Current Opinion in Endocrinology & Diabetes | 2003 |
Sounding board: diabetes mellitus in the elderly: a truly heterogeneous entity?
S Ratnakant, ME Ochs, SS Solomon |
Diabetes, Obesity and Metabolism | 2003 |
Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
DJ Drucker |
Expert Opinion on Investigational Drugs | 2003 |
Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2
PL Brubaker, Y Anini |
Canadian Journal of Physiology and Pharmacology | 2003 |
Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells
A Suzuki, H Nakauchi, H Taniguchi |
Proceedings of the National Academy of Sciences | 2003 |
Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling
A Bavec, M Hällbrink, Ü Langel, M Zorko |
Regulatory Peptides | 2003 |
Glucose-dependent insulinotropic polypeptide: its role in glucose and lipid homeostasis:
CC Tseng |
Current Opinion in Endocrinology & Diabetes | 2003 |
[2-Sulfo-9-fluorenylmethoxycarbonyl]3–exendin-4—a long-acting glucose-lowering prodrug
Y Shechter, H Tsubery, M Fridkin |
Biochemical and Biophysical Research Communications | 2003 |
Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons
N Vrang, CB Phifer, MM Corkern, HR Berthoud |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2003 |
Clinical Significance of GLP-2 in Short-Bowel Syndrome
PB Jeppesen |
The Journal of nutrition | 2003 |
Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide: Potential Applications in Type 2 Diabetes Mellitus
JJ Meier, B Gallwitz, MA Nauck |
BioDrugs | 2003 |
Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1
D Delmeire, D Flamez, SA Hinke, JJ Cali, D Pipeleers, F Schuit |
Diabetologia | 2003 |
Enhancing bowel adaptation in short bowel syndrome
PB Jeppesen, PB Mortensen |
Current Gastroenterology Reports | 2002 |
Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1
LL Baggio, DJ Drucker |
Treatments in Endocrinology | 2002 |
Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis
Z Gao, RA Young, MM Trucco, SR Greene, EL Hewlett, FM Matschinsky, BA Wolf |
Biochemical Journal | 2002 |
Insulin Resistance and Insulin Resistance Syndrome
A Cincotta |
Insulin Resistance and Insulin Resistance Syndrome | 2002 |
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
DJ Drucker |
Molecular Endocrinology | 2002 |
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective
CF Deacon, JJ Holst |
Biochemical and Biophysical Research Communications | 2002 |
Biological actions and therapeutic potential of the glucagon-like peptides
DJ Drucker |
Gastroenterology | 2002 |
Structure-Function of the Glucagon Receptor Family of G Protein-Coupled Receptors: The Glucagon, GIP, GLP-1, and GLP-2 Receptors
PL Brubaker, DJ Drucker |
Receptors and Channels | 2002 |
Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
Y Anini, T Hansotia, PL Brubaker |
Endocrinology | 2002 |
cDNA Cloning of Proglucagon from the Stomach and Pancreas of the Dog
DM Irwin |
Mitochondrial DNA | 2001 |
Amphibian glucagon family peptides: potent metabolic regulators in fish hepatocytes
TP Mommsen, JM Conlon, DM Irwin |
Regulatory Peptides | 2001 |
The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the l-arginine/nitric oxide pathway
T Tolessa, E Näslund, PM Hellström |
Regulatory Peptides | 2001 |
Identification of a Proglucagon cDNA from Rana tigrina rugulosa That Encodes Two GLP-1s and That Is Alternatively Spliced in a Tissue-Specific Manner
CM Yeung, BK Chow |
General and Comparative Endocrinology | 2001 |
Evolution of receptors for proglucagon-derived peptides: isolation of frog glucagon receptors
P Sivarajah, MB Wheeler, DM Irwin |
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology | 2001 |
New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2
D J Drucker, J Lovshin, L Baggio, M Nian, F Adatia, R P Boushey, Y Liu, J Saleh, B Yusta, L Scrocchi |
Annals of the New York Academy of Sciences | 2001 |
GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve
A Brandt, M Katschinski, R Arnold, KS Polonsky, B Göke, MM Byrne |
American journal of physiology. Endocrinology and metabolism | 2001 |
A Glucagon-Like Peptide-1 Receptor Agonist and an Antagonist Modify Macronutrient Selection by Rats
CT Peters, YH Choi, PL Brubaker, GH Anderson |
The Journal of nutrition | 2001 |
An Interaction between Hypothalamic Glucagon-Like Peptide-1 and Macronutrient Composition Determines Food Intake in Rats
YH Choi, GH Anderson |
The Journal of nutrition | 2001 |
Monounsaturated Fatty Acid Diets Improve Glycemic Tolerance through Increased Secretion of Glucagon-Like Peptide-1*
AS Rocca, J LaGreca, J Kalitsky, PL Brubaker |
Endocrinology | 2001 |
Molecular Basis of Pancreas Development and Function
JF Habener, MA Hussain |
2001 | |
Ontogeny of intestinal nutrient transport
A Thiesen, G Wild, M Keelan, MT Clandinin, M McBurney, JV Aerde, AB Thomson |
Canadian Journal of Physiology and Pharmacology | 2000 |
Fructo-Oligosaccharide Supplementation: Effects on Metabolic, Endocrine and Hematological Traits in Veal Calves
J Kaufhold, HM Hammon, JW Blum |
Journal of Veterinary Medicine Series A | 2000 |
Proglucagon cDNAs from the Leopard Frog, Rana pipiens, encode two GLP-1-like peptides
DM Irwin, P Sivarajah |
Molecular and Cellular Endocrinology | 2000 |
Effect of Glucagon-Like Peptide 1(7-36)Amide in Insulin-Treated Patients with Diabetes Mellitus Secondary to Chronic Pancreatitis
C Hedetoft, SP Sheikh, S Larsen, JJ Holst |
Pancreas | 2000 |
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon
PB Jeppesen, B Hartmann, J Thulesen, BS Hansen, JJ Holst, SS Poulsen, PB Mortensen |
Gut | 2000 |
Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research
JM Conlon |
Regulatory Peptides | 2000 |
Augmentation of Alimentary Insulin Secretion despite Similar Gastric Inhibitory Peptide (GIP) Responses in Juvenile Obesity
RA Heptulla, WV Tamborlane, M Cavaghan, M Bronson, C Limb, MA Yong-Zhan, RS Sherwin, S Caprio |
Pediatric Research | 2000 |
The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor
M Nishizawa, H Nakabayashi, K Kawai, T Ito, S Kawakami, A Nakagawa, A Niijima, K Uchida |
Journal of the Autonomic Nervous System | 2000 |
Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum
C Herrmann–Rinke, GP McGregor, B Göke |
Peptides | 2000 |
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish
S Mojsov |
American Zoologist | 2000 |
Glucagon-like Peptide-1 in Fishes: The Liver and Beyond
TP Mommsen |
American Zoologist | 2000 |
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish1
S Mojsov |
American Zoologist | 2000 |
Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum
L Hansen, B Hartmann, T Bisgaard, H Mineo, PN Jørgensen, JJ Holst |
American journal of physiology. Endocrinology and metabolism | 2000 |
Adaptive changes in insulin secretion by islets from neonatal rats raised on a high-carbohydrate formula
M Srinivasan, R Aalinkeel, F Song, B Lee, SG Laychock, MS Patel |
American journal of physiology. Endocrinology and metabolism | 2000 |
Neuroendocrine Function and Response to Stress in Mice with Complete Disruption of Glucagon-Like Peptide-1 Receptor Signaling1
NJ MacLusky, S Cook, L Scrocchi, J Shin, J Kim, F Vaccarino, SL Asa, DJ Drucker |
Endocrinology | 2000 |
The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon Superfamily*
NM Sherwood, SL Krueckl, JE McRory |
Endocrine reviews | 2000 |
Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
M Hiroyoshi, K Tateishi, Y Yasunami, K Maeshiro, J Ono, Y Matsuoka, S Ikeda |
The American Journal of Gastroenterology | 1999 |
Encapsulated, Genetically Engineered Cells, Secreting Glucagon-like Peptide-1 for the Treatment of Non-insulin-dependent Diabetes Mellitus
R Burcelin, E Rolland, W Dolci, S Germain, V Carrel, B Thorens |
Annals of the New York Academy of Sciences | 1999 |
Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice
DQ Shih, MA Navas, S Kuwajima, SA Duncan, M Stoffel |
Proceedings of the National Academy of Sciences | 1999 |
Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1
R Burcelin, W Dolci, B Thorens |
Metabolism | 1999 |
Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha -deficient mice
DQ Shih, MA Navas, S Kuwajima, SA Duncan, M Stoffel |
Proceedings of the National Academy of Sciences | 1999 |
Insulin and Proglucagon-Derived Peptides from the Horned Frog, Ceratophrys ornata (Anura:Leptodactylidae)
AM White, SM Secor, JM Conlon |
General and Comparative Endocrinology | 1999 |
Immunoblockade of endogenous glucagon-like peptide-1 by monoclonal antibodies in conscious rats: Effect on the insulin response to intragastric glucose
J Delft, O Uttenthal, C Koch, M Ghiglione |
Metabolism | 1999 |
Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain
JA Chowen, FR Fonseca, E Alvarez, M Navarro, LM Garcı́a-Segura, E Blázquez |
Neuropeptides | 1999 |
Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice
B Ahrén, G Pacini |
American journal of physiology. Endocrinology and metabolism | 1999 |
Effect of GIP and GLP-1 antagonists on insulin release in the rat
CC Tseng, XY Zhang, MM Wolfe |
American journal of physiology. Endocrinology and metabolism | 1999 |
Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion*
AS Rocca, PL Brubaker |
Endocrinology | 1999 |
Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin
T Tolessa, M Gutniak, JJ Holst, S Efendic, PM Hellström |
Journal of Clinical Investigation | 1998 |
Glucagon-like peptide-1 (7–36) amide as a novel neuropeptide
E Blázquez, E Alvarez, M Navarro, I Roncero, F Rodríguez-Fonseca, JA Chowen, JA Zueco |
Molecular Neurobiology | 1998 |
Structure-function analysis of a series of glucagon-like peptide-1 analogs
JC Parker, KM Andrews, DM Rescek, W Massefski, GC Andrews, LG Contillo, RW Stevenson, DH Singleton, RT Suleske |
The Journal of Peptide Research | 1998 |
Stimulatory Transducing Systems in Pancreatic Islet Cellsa
S Emami, K Regnauld, N Ferrand, A Astesano, M Pessah, H Phan, C Boissard, JM Garel, G Rosselin |
Annals of the New York Academy of Sciences | 1998 |
Central infusion of glucagon-like peptide-1-(7–36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem
TE Thiele, RJ Seeley, D D'Alessio, J Eng, IL Bernstein, SC Woods, G Dijk |
Brain Research | 1998 |
Proglucagon and Glucose Transporter mRNA Is Altered by Diet and Disease Susceptibility in 30-Day-Old Biobreeding (BB) Diabetes-Prone and Normal Rats
RA Reimer, S Glen, CJ Field, MI McBurney |
Pediatric Research | 1998 |
Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms
T Tolessa, M Gutniak, J J Holst, S Efendic, P M Hellström |
Digestive Diseases and Sciences | 1998 |
Fermentable Dietary Fiber Increases GLP-1 Secretion and Improves Glucose Homeostasis Despite Increased Intestinal Glucose Transport Capacity in Healthy Dogs
SP Massimino, MI McBurney, CJ Field, AB Thomson, M Keelan, MG Hayek, GD Sunvold |
The Journal of nutrition | 1998 |
Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects
E Ferrannini |
Endocrine reviews | 1998 |
Effects of Aging and a High Fat Diet on Body Weight and Glucose Tolerance in Glucagon-Like Peptide-1 Receptor−/− Mice*
LA Scrocchi, DJ Drucker |
Endocrinology | 1998 |
Glucagon-Like Peptide-1-(7–36)Amide Increases Pulmonary Surfactant Secretion through a Cyclic Adenosine 3′,5′-Monophosphate-Dependent Protein Kinase Mechanism in Rat Type II Pneumocytes*
E Benito, E Blazquez, MA Bosch |
Endocrinology | 1998 |
GLP-1 Receptors in Golden Syrian Hamster Islets: Identification and Functional Characterization
G Rosselin, V Leclercq-Meyer, C Boissart, M Pessah, WJ Malaisse |
Endocrine | 1998 |
Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid
M Anvari, C A Paterson, E E Daniel, T J McDonald |
Digestive Diseases and Sciences | 1998 |
Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release
PL Brubaker, S Efendic, GR Greenberg |
Endocrine | 1997 |
ENTEROGLUCAGON
JJ Holst |
Annual Review of Physiology | 1997 |
The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties
DM Irwin, M Satkunarajah, Y Wen, PL Brubaker, RA Pederson, MB Wheeler |
Proceedings of the National Academy of Sciences | 1997 |
Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon
Y Rouillé, M Bianchi, JC Irminger, PA Halban |
FEBS Letters | 1997 |
Acute Incretin Response to Oral Glucose Is Associated with Stimulation of Gastric Inhibitory Polypeptide, Not Glucagon-Like Peptide in Young Subjects
C Limb, WV Tamborlane, RS Sherwin, R Pederson, S Caprio |
Pediatric Research | 1997 |
Endoproteolysis of Glucagon-like Peptide (GLP)-1(7–36) amide by Ectopeptidases in RINm5F Cells
K Hupe-Sodmann, R Göke, B Göke, HH Thole, B Zimmermann, K Voigt, GP McGregor |
Peptides | 1997 |
Activation of the hepatic glycine cleavage enzyme system by glucagon and glucagon-related peptides
GM Mabrouk, JT Brosnan |
Canadian Journal of Physiology and Pharmacology | 1997 |
Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2
PL Brubaker, A Izzo, M Hill, DJ Drucker |
American journal of physiology. Endocrinology and metabolism | 1997 |
Physiology and Pathophysiology of the Islets of Langerhans
B Soria |
1997 | |
Circulating and Tissue Forms of the Intestinal Growth Factor, Glucagon-Like Peptide-2*
PL Brubaker, A Crivici, A Izzo, P Ehrlich, CH Tsai, DJ Drucker |
Endocrinology | 1997 |
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons
DA D'Alessio, R Vogel, R Prigeon, E Laschansky, D Koerker, J Eng, JW Ensinck |
Journal of Clinical Investigation | 1996 |
Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37)
YA Hosokawa, H Hosokawa, C Chen, JL Leahy |
Journal of Clinical Investigation | 1996 |
Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat
CC Tseng, TJ Kieffer, LA Jarboe, TB Usdin, MM Wolfe |
Journal of Clinical Investigation | 1996 |
Regulation of glucagon-like peptide-I receptor expression and transcription by the protein kinase C pathway
HC Fehmann, J Schweinfurth, J Jiang, B Göke |
Research in Experimental Medicine | 1996 |
Wege der Nachrichtenübermittlung bei der Stimulation der Sekretion von Insulin
HP Ammon |
Pharmazie in unserer Zeit | 1996 |
Time-dependent effects of cholinergic stimulation on beta cell responsiveness
WS Zawalich, KC Zawalich, GG Kelley |
Pflügers Archiv - European Journal of Physiology | 1996 |
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene
LA Scrocchi, TJ Brown, N Maclusky, PL Brubaker, AB Auerbach, AL Joyner, DJ Drucker |
Nature Medicine | 1996 |
Pancreatic β-Cell Receptors and G Proteins Coupled to Adenylyl Cyclase
JC Marie, G Rosselin, G Skoglund |
Annals of the New York Academy of Sciences | 1996 |
On the Effects of Glucagon-Like Peptide-1 on Blood Glucose Regulation in Normal and Diabetic Subjects
JJ Holst, MB Toft-Nielsen, C Ørskov, M Nauck, B Willms |
Annals of the New York Academy of Sciences | 1996 |
Synthesis and Biochemical Characterization of Proglucagon- Related Peptides
N Yanaihara, T Mochizuki, T Satoh, S Imai, K Sasaki, H Kakuyama, H Hosoe, N Takatsuka, K Iguchi, WQ Luo, N Kurokawa, C Yanaihara |
Annals of the New York Academy of Sciences | 1996 |
Endoprotease Regulation of Miniglucagon Production
D Bataille, P Blache, F Bergeron |
Annals of the New York Academy of Sciences | 1996 |
Induction of intestinal epithelial proliferation by glucagon-like peptide 2
DJ Drucker, P Erlich, SL Asa, PL Brubaker |
Proceedings of the National Academy of Sciences | 1996 |
Proglucagon processing in islet and intestinal cell lines
JD Tucker, S Dhanvantari, PL Brubaker |
Regulatory Peptides | 1996 |
Expression of glucagon-like peptide 1 receptor in a murine C cell line Regulation of calcitonin gene by glucagon-like peptide 1
Y Lamari, C Boissard, MS Moukhtar, A Jullienne, G Rosselin, JM Garel |
FEBS Letters | 1996 |
Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol
WS Zawalich, KC Zawalich |
Metabolism | 1996 |
Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1
H Nakabayashi, M Nishizawa, A Nakagawa, R Takeda, A Niijima |
American journal of physiology. Endocrinology and metabolism | 1996 |
Mechanisms of inhibition of insulin release
GW Sharp |
American journal of physiology. Cell physiology | 1996 |
Glucagon III
PJ Lefèbvre |
1996 | |
Glucagon-like peptide-1 is a physiological incretin in rat
Z Wang, RM Wang, AA Owji, DM Smith, MA Ghatei, SR Bloom |
Journal of Clinical Investigation | 1995 |
Drugs on the Horizon for Treatment of Type 2 Diabetes
J Rachman, RC Turner |
Diabetic Medicine | 1995 |
Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis
YT Kruszynska, MA Ghatei, SR Bloom, N McIntyre |
Hepatology | 1995 |
Mechanism of action of glucagon-like peptide-17–36NH2 in isolated rat pancreatic islets and abrogation of its effects in long-term incubations
KA Gronau, PL Brubaker |
Endocrine | 1995 |
Synthesis and secretion of glucagon-like peptide-1 by fetal rat intestinal cells in culture
TH Huang, PL Brubaker |
Endocrine | 1995 |
Glucagon-like peptide-1(7–36)amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat
JC Calvo, CV Gisolfi, E Blazquez, F Mora |
Brain Research Bulletin | 1995 |
Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7–36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides
K Hupe-Sodmann, GP McGregor, R Bridenbaugh, R Göke, B Göke, H Thole, B Zimmermann, K Voigt |
Regulatory Peptides | 1995 |
Advances in Drug Research
CL Crespi |
Advances in Drug Research | 1995 |
Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1
GG 4th, CA Leech, JF Habener |
The Journal of biological chemistry | 1995 |
Activation of a cAMP-regulated Ca2+-Signaling Pathway in Pancreatic β-Cells by the Insulinotropic Hormone Glucagon-like Peptide-1*
GG Holz, CA Leech, JF Habener |
The Journal of biological chemistry | 1995 |
Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion
X Jia, JC Brown, P Ma, RA Pederson, CH McIntosh |
American journal of physiology. Endocrinology and metabolism | 1995 |
Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1
GG Holz, CA Leech, JF Habener |
The Journal of biological chemistry | 1995 |
Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like Peptide
Y Rouillé, S Martin, DF Steiner |
The Journal of biological chemistry | 1995 |
Evidence that glucagon stimulates insulin secretion through its own receptor in rats
K Kawai, C Yokota, S Ohashi, Y Watanabe, K Yamashita |
Diabetologia | 1995 |
Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (?TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells
, M Janen, B Gke |
Acta Diabetologica | 1995 |
Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus: Effect of sulfonylurea therapy
N Fukase, H Manaka, K Sugiyama, H Takahashi, M Igarashi, M Daimon, K Yamatani, M Tominaga, H Sasaki |
Acta Diabetologica | 1995 |
The pathogenesis of NIDDM: the role of the pancreatic beta cell.
Zawalich WS, Kelley GG |
Diabetologia | 1995 |
Structure/Activity Characterization of Glucagon-Like Peptide-1
B Gallwitz, M Witt, G Paetzold, C Morys-Wortmann, B Zimmermann, K Eckart, UR Folsch, WE Schmidt |
European Journal of Biochemistry | 1994 |
Interaction of glucagon-like peptide-I (7–37) and somatostatin-14 on signal transduction and proinsulin gene expression in βTC-1 cells
HC Fehmann, M Strowski, B Göke |
Metabolism | 1994 |
Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas
K Tateishi, K Shima, A Funakoshi, Y Yasunami, N Iwamoto, Y Matsuoka |
Diabetes Research and Clinical Practice | 1994 |
The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects
D Elahi, M McAloon-Dyke, NK Fukagawa, GS Meneilly, AL Sclater, KL Minaker, JF Habener, DK Andersen |
Regulatory Peptides | 1994 |
A novel procedure for the preparation of biologically active recombinant peptides using a cyanylation reaction
N Koyama, M Kuriyama, N Amano, O Nishimura |
Journal of Biotechnology | 1994 |
Primary structures of peptides derived from proglucagon isolated from the pancreas of the elasmobranch fish, Scyliorhinus canicula
JM Conlon, N Hazon, L Thim |
Peptides | 1994 |
Glucagonlike peptide 1: A newly discovered gastrointestinal hormone
JJ Holst |
Gastroenterology | 1994 |
Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice
DJ Drucker |
American journal of physiology. Endocrinology and metabolism | 1994 |
Molecular Biology of Diabetes
B Draznin, D LeRoith |
1994 | |
Physiologic relevance of heterogeneity in the pancreatic beta-cell population
D Pipeleers, R Kiekens, Z Ling, A Wilikens, F Schuit |
Diabetologia | 1994 |
Structure-activity studies of glucagon-like peptide-1
K Adelhorst, BB Hedegaard, LB Knudsen, O Kirk |
The Journal of biological chemistry | 1994 |
Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells
T Yada, M Sakurada, K Ihida, M Nakata, F Murata, A Arimura, M Kikuchi |
The Journal of biological chemistry | 1994 |
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
MA Nauck, MM Heimesaat, C Orskov, JJ Holst, R Ebert, W Creutzfeldt |
Journal of Clinical Investigation | 1993 |
Metabolic and endocrine functions of glucagon-like peptides — evolutionary and biochemical perspectives
TP Mommsen, EM Plisetskaya |
Fish Physiology and Biochemistry | 1993 |
Hypersecretion of Truncated Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide in Obese Patients
N Fukase, M Igarashi, H Takahashi, H Manaka, K Yamatani, M Daimon, M Tominaga, H Sasaki |
Diabetic Medicine | 1993 |
Structure and biological activity of glucagon and glucagon-like peptide from a primitive bony fish, the bowfin (Amia calva)
JM Conlon, JH Youson, TP Mommsen |
Biochemical Journal | 1993 |
Influence of glucagon-like peptide-1 on β cell responsiveness
WS Zawalich, KC Zawalich, H Rasmussen |
Regulatory Peptides | 1993 |
Glucagon-like peptide-I-(7–37) suppresses hyperglycemia in rats
GK Hendrick, A Gjinovci, LA Baxter, S Mojsov, CB Wollheim, JF Habener, GC Weir |
Metabolism | 1993 |
Effects of glucagon-like peptide-1(7-36)amide on the concentrations of insulin and glucose in sheep
PA Martin, A Faulkner |
Comparative Biochemistry and Physiology Part A: Physiology | 1993 |
Neurotrophic Factors
DN Ishii |
Neurotrophic Factors | 1993 |
Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)
GG Holz, WM Kiihtreiber, JF Habener |
Nature | 1993 |
The Incretin Notion and its Relevance to Diabetes
JF Habener |
Endocrinology and metabolism clinics of North America | 1993 |
Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation
MA Nauck, M Bsing, C rskov, EG Siegel, J Talartschik, A Baartz, T Baartz, UT Hopt, , W Creutzfeldt |
Acta Diabetologica | 1993 |
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
A Wettergren, B Schjoldager, PE Mortensen, J Myhre, J Christiansen, JJ Holst |
Digestive Diseases and Sciences | 1993 |
Peptides 1992
CH Schneider, AN Eberle |
1993 | |
Gut hormones and diabetes mellitus
W Creutzfeldt, M Nauck |
Diabetes / Metabolism Reviews | 1992 |
Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin
HC Fehmann, R Göke, B Göke |
Molecular and Cellular Endocrinology | 1992 |
Decrease in plasma GLP-1 immunoreactivity in starved rats
J Takahashi, Y Noma, S Yoshimoto, C Fujita, K Shima |
Diabetes Research and Clinical Practice | 1992 |
Coexistence of glucagon and pancreatic polypeptide in human and rat pancreatic endocrine cells
IS Park, M Bendayan |
Endocrine Pathology | 1992 |
Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man
R Eissele, R Göke, S Willemer, HP Harthus, H Vermeer, R Arnold, B Göke |
European Journal of Clinical Investigation | 1992 |
Comparison of the effect of GIP and GLP-1 (7–36amide) on insulin release from rat pancreatic islets
EG Siegel, A Schulze, WE Schmidt, W Creutzfeldt |
European Journal of Clinical Investigation | 1992 |
Signal transduction crosstalk in the endocrine system: pancreatic β-cells and the glucose competence concept
GG Holz, JF Habener |
Trends in Biochemical Sciences | 1992 |
Structural requirements for biological activity of glucagon-like peptide-I
S Mojsov |
International Journal of Peptide and Protein Research | 1992 |
Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone
HC Fehmann, JF Habener |
Trends in Endocrinology & Metabolism | 1992 |
Solubilization of active GLP-1 (7–36)amide receptors from RINm5F plasma membranes
R Göke, B Oltmer, SP Sheikh, B Göke |
FEBS Letters | 1992 |
Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept
GG Holz, JF Habener |
Trends in Biochemical Sciences | 1992 |
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1
B Thorens |
Proceedings of the National Academy of Sciences | 1992 |
Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain
LO Uttenthal, A Toledano, E Blázquez |
Neuropeptides | 1992 |
Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas
S Suzuki, K Kawai, S Ohashi, Y Watanabe, K Yamashita |
Metabolism | 1992 |
Diabetes and Atherosclerosis
RW Stout |
1992 | |
Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4
JP Raufman, L Singh, G Singh, J Eng |
The Journal of biological chemistry | 1992 |
Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene
PL Brubaker, YC Lee, DJ Drucker |
The Journal of biological chemistry | 1992 |
Glucagon-like peptide-1, a new hormone of the entero-insular axis
C Orskov |
Diabetologia | 1992 |
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine
C Orskov, J Jeppesen, S Madsbad, JJ Holst |
Journal of Clinical Investigation | 1991 |
Priming effect of glucagon-like peptide-1 (7–36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas
HC Fehmann, R Göke, B Göke, R Bächle, B Wagner, R Arnold |
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 1991 |
Hormonal regulation of metabolism in hepatocytes of the ureogenic teleostopsanus beta
TP Mommsen, E Danulat, PJ Walsh |
Fish Physiology and Biochemistry | 1991 |
Glucagon-like peptide-1(7–36) amide is a new incretin/enterogastrone candidate
R Göke, HC Fehmann, B Göke |
European Journal of Clinical Investigation | 1991 |
Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7–37) on a somatostatin secreting cell line
HC Fehmann, JF Habener |
FEBS Letters | 1991 |
Hyperglycaemia but not hyperinsulinaemia prevents the secretion of glucagon-like peptide-1 (7-36 amide) stimulated by fat ingestion
H Takahashi, H Manaka, K Suda, N Fukase, A Sekikawa, H Eguchi, M Tominaga, H Sasaki |
Scandinavian Journal of Clinical & Laboratory Investigation | 1991 |
Absence of insulinotropic glucagon-like peptide-I(7–37) receptors on isolated rat liver hepatocytes
PF Blackmore, S Mojsov, JH Exton, JF Habener |
FEBS Letters | 1991 |
Characterization of glucagon-like peptide-I(7–36)amide receptors of rat lung membranes by covalent cross-linking
G Richter, R Göke, B Göke, H Schmidt, R Arnold |
FEBS Letters | 1991 |
International Review of Cytology
RA Miller |
International Review of Cytology | 1991 |
The primary structure of Glucagon-like peptide but not insulin has been conserved between the American eel, Anguilla rostrata and the European eel, Anguilla anguilla
JM Conlon, PC Andrews, L Thim, TW Moon |
General and Comparative Endocrinology | 1991 |
Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy
J Miholic, C rskov, JJ Holst, J Kotzerke, HJ Meyer |
Digestive Diseases and Sciences | 1991 |
Endocrine pancreas of teleost fish: A model for interaction of islet hormones?
EM Plisetskaya |
Journal of Experimental Zoology | 1990 |
Gut signals for islet hormone release
R Ebert |
European Journal of Clinical Investigation | 1990 |
Alterations of plasma immunoreactive glucagon-like peptide-1 behavior in non-insulin-dependent diabetics
M Hirota, M Hashimoto, M Hiratsuka, C Ohboshi, S Yoshimoto, M Yano, A Mizuno, K Shima |
Diabetes Research and Clinical Practice | 1990 |
Characterization of receptors for glucagon-like peptide-1(7–36) amide on rat lung membranes
G Richter, R Göke, B Göke, R Arnold |
FEBS Letters | 1990 |
Gastrointestinal Endocrinology
CC Wang, YH Tu, WY Zhu |
Gastrointestinal Endocrinology | 1990 |
Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7–36 amide) without affect on mRNA level in isolated rat islets
E Yamato, Y Noma, Y Tahara, H Ikegami, Y Yamamoto, T Cha, H Yoneda, T Ogihara, C Ohboshi, M Hirota, K Shima |
Biochemical and Biophysical Research Communications | 1990 |
Action of glucagon and glucagon-like peptide on glycogen metabolism of trout isolated hepatocytes
AC Puviani, C Otiolenghi, ME Gavioli, E Fabbri, L Brighenti |
Comparative Biochemistry and Physiology Part B: Comparative Biochemistry | 1990 |
Effect of Glucagon-Like Peptide-1 on Gastric Somatostatin and Gastrin Secretion in the Rat
R Eissele, H Koop, R Arnold |
Scandinavian Journal of Gastroenterology | 1990 |
The epidermal growth factor precursor isolated from murine kidney membranes. Chemical characterization and biological properties
JA Breyer, S Cohen |
The Journal of biological chemistry | 1990 |
Functional characterization of a cAMP-responsive element of the rat insulin I gene
J Philippe, M Missotten |
The Journal of biological chemistry | 1990 |
Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom
J Eng, PC Andrews, WA Kleinman, L Singh, JP Raufman |
The Journal of biological chemistry | 1990 |
Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas
S Mojsov, MG Kopczynski, JF Habener |
The Journal of biological chemistry | 1990 |
A physiologic role for somatostatin 28 as a regulator of insulin secretion
DA D'Alessio, C Sieber, C Beglinger, JW Ensinck |
Journal of Clinical Investigation | 1989 |
Effects of four orally administered analogues of prostaglandin E1and E2on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man
M Nauck, S Härter, R Ebert, W Creutzfeldt |
European Journal of Clinical Investigation | 1989 |
Glycogenolytic action of glucagon-family peptides and epinephrine on catfish hepatocytes
C Ottolenghi, AC Puviani, ME Gavioli, E Fabbri, L Brighenti, EM Plisetskaya |
Fish Physiology and Biochemistry | 1989 |
Internalization of glucagon-like peptide-1(7–36)amide in rat insulinoma cells
R Göke, G Richter, B Göke, M Trautmann, R Arnold |
Research in Experimental Medicine | 1989 |
Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine
DJ Drucker, PL Brubaker |
Proceedings of the National Academy of Sciences | 1989 |
Synergistic stimulatory effect of glucagon-like peptide-1 (7–36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas
HC Fehmann, B Göke, R Göke, ME Trautmann, R Arnold |
FEBS Letters | 1989 |
Metabolic effects of salmon glucagon and glucagon-like peptide in coho and chinook salmon
EM Plisetskaya, C Ottolenghi, MA Sheridan, TP Mommsen, A Gorbman |
General and Comparative Endocrinology | 1989 |
Distribution and molecular forms of glucagon-like peptide in the dog
K Suda, H Takahashi, N Fukase, H Manaka, M Tominaga, H Sasaki |
Life Sciences | 1989 |
The Comparative Physiology of Regulatory Peptides
S Holmgren |
1989 | |
GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans
BT Schjoldager, PE Mortensen, J Christiansen, C rskov, JJ Holst |
Digestive Diseases and Sciences | 1989 |
Complete Sequences of Glucagon-like Peptide-1 from Human and Pig Small Intestine
C Orskov, M Bersani, AH Johnsen, P Højrup, JJ Holst |
The Journal of biological chemistry | 1989 |
Proglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles
JM Conlon |
Diabetologia | 1988 |
Glucagon-like peptide-1 (7–36 amide): a potent glucagonostatic and insulinotropic hormone
T Matsuyama, R Komatsu, M Namba, N Watanabe, H Itoh, S Tarui |
Diabetes Research and Clinical Practice | 1988 |
Comparison of half-disappearance times, distribution volumes and metabolic clearance rates of exogenous glucagon-like peptide 1 and glucagon in rats
I Oshima, M Hirota, C Ohboshi, K Shima |
Regulatory Peptides | 1988 |
Effect of glucagon-like peptide-1 on insulin secretion
K Shima, M Hirota, C Ohboshi |
Regulatory Peptides | 1988 |
Effect of truncated glucagon-like peptide 1 on cAMP in rat gastric glands and HGT-1 human gastric cancer cells
AB Hansen, CP Gespach, GE Rosselin, JJ Holst |
FEBS Letters | 1988 |
Truncated glucagon-like peptide-1 (proglucagon 78–107 amide), an intestinal insulin-releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH)
C Ørskov, JH Nielsen |
FEBS Letters | 1988 |
Identification and characterization of glucagon-like peptide-1 7–36 amide-binding sites in the rat brain and lung
SM Kanse, B Kreymann, MA Ghatei, SR Bloom |
FEBS Letters | 1988 |
Isolation of alligator gar (Lepisosteus spatula) glucagon, oxyntomodulin, and glucagon-like peptide: Amino acid sequences of oxyntomodulin and glucagon-like peptide
HG Pollock, JR Kimmel, KE Ebner, JW Hamilton, JB Rouse, V Lance, AB Rawitch |
General and Comparative Endocrinology | 1988 |
Peptides
GR Marshall |
Peptides | 1988 |
Colocalization of glucagon-like peptide and glucagon immunoreactivities in pancreatic islets and intestine of salmonids
M Nozaki, K Miyata, Y Oota, A Gorbman, EM Plisetskaya |
Cell and Tissue Research | 1988 |
GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN
B Kreymann, MA Ghatei, G Williams, SR Bloom |
The Lancet | 1987 |
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
DJ Drucker, J Philippe, S Mojsov, WL Chick, JF Habener |
Proceedings of the National Academy of Sciences | 1987 |
Glucagon-like peptides activate hepatic gluconeogenesis
TP Mommsen, PC Andrews, EM Plisetskaya |
FEBS Letters | 1987 |
Effect of the enteroinsular axis on both the A- and B-cell response to arginine after oral glucose in man
I Shimizu, M Hirota, C Ohboshi, A Mizuno, K Shima |
Diabetologia | 1987 |
Pancreatic and intestinal processing of proglucagon in man
C Orskov, J J Holst, S S Poulsen, P Kirkegaard |
Diabetologia | 1987 |
Progress in Medicinal Chemistry
JR Brown, SH Imam |
Progress in Medicinal Chemistry | 1985 |
Advances in Metabolic Disorders
G Aurbach, JT Potts |
Advances in Metabolic Disorders | 1964 |